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Thesis Portfolio Abstract 
Aims: The present thesis portfolio sought to contribute to understanding the mechanisms 
of change in mental health treatment, by exploring the association between the 
idiosyncratic client-specific factor of personality traits and outcomes of treatment. 
Specifically, it sought to understand whether (a) client personality traits predict the 
outcomes of psychological intervention, and (b) there is a significant relationship between 
personality traits and treatment outcomes in forensic mental health services (FMHS). 
Design: Two pieces of research were undertaken. A systematic review synthesised the 
available literature to understand whether five-factor model (FFM; Costa & McCrae, 1990) 
traits have been shown to predict clinical and psychosocial outcomes of empirically 
supported psychological interventions. An empirical research project measured the amount 
of change patients in FMHS showed in clinical and risk factors, after a considerable period 
of treatment (18 months), and correlated this with patients’ scores on a measure of their 
personality traits. Results: The systematic review identified few studies that explored the 
predictive role of personality traits for outcomes of psychological interventions. Within 
these, few significant predictive relationships were found. Conscientiousness showed the 
most predictive value for treatment outcomes. The empirical project found little significant 
change in clinical and risk outcomes following long-term inpatient treatment and it was 
therefore not possible to determine whether there was a significant relationship with 
personality traits. Conclusions: Both studies identified challenges to investigating the 
impact of client personality traits on the course and outcomes of treatment. These include 
the complexity of the possible interaction of numerous variables in the course of treatment, 
and the heterogeneity in the research designs and methods used to investigate them. 
Further research is needed to understand the impact personality traits have on treatment, 
both as predictors, and moderators for other idiosyncratic variables. Further research is 
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Chapter 1: Introduction to Thesis Portfolio 
In Mental Health Services, treatment can consist of a combination of psychological 
interventions, medication, case management, support groups, hospitalisation, creative 
therapies, and alternative and complementary therapies. Psychological interventions can 
be defined as “actions intended to modify processes and systems that are social and 
psychological in nature (such as cognitions, emotions, behaviours, norms, relationships, 
and environments) and are hypothesised to influence outcomes of interest” (Grant et al., 
2018, p. 2). The term “psychological interventions” will be used interchangeably with 
“psychological therapies” and “therapies” in this thesis portfolio.  
The field of research into the outcomes of psychological interventions for various 
psychological difficulties and clinical disorders has shown that therapies from different 
therapeutic frameworks often do not consistently produce evidence of superiority in 
effectiveness (e.g. Cuijpers et al., 2013; Wampold & Imel, 2015). An ensuing debate has 
arisen surrounding the causes for such discrepant findings. Some researchers postulate 
that outcomes of psychological interventions are mainly attributed to common extra-
therapeutic factors (e.g. Lambert, 1992) rather than elements of the therapies. They also 
postulate that therapies are not entirely separate as they have common factors; for 
example, studies have shown that therapists from different orientations exhibit similar 
behaviours during treatment (e.g. Trijsburg, Trent, & Perry, 2004). Imel and Wampold 
(2008) found that non-therapeutic modality specific factors account for 30-70% of variance 
in outcomes. Other researchers argue that specific elements of the different therapies are 
responsible for the effectiveness of treatment (e.g. DeRubeis, Brotman, & Gibbons, 2005), 
and this is often supported by evidence that certain therapies consistently show greater 
outcomes in some areas, such as Cognitive-Behavioural Therapy (CBT) for major depression 
and anxiety disorders (Cuijpers, Cristea, Karyotaki, Reijnders, & Huibers, 2016). 
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Still others argue that the methodology for research into treatment effectiveness is 
itself problematic, and influences the findings. For example, Budd and Hughes (2009) and 
Westen, Novotny, and Thompson-Brenner (2004) postulate that randomised controlled 
trials (RCTs) are unable to effectively compare psychological therapies, because treating 
psychological interventions as separate entities denies the common elements between 
them. Furthermore, the reliability and validity of the findings from research into treatment 
effectiveness may be argued to suffer from a number of established difficulties, such as 
publication bias (whereby many studies that do not find significant results are not 
published, Dal-Ré et al., 2017), researcher allegiance (i.e. the researcher’s belief in the 
validity and superiority of their treatment, Munder et al., 2013), and deficits in the integrity 
of the research method (e.g. randomisation and blinding in RCTs) and delivery of the 
investigated treatment (Cuijpers, van Straten, Bohlmeijer, Hollon, & Andersson, 2010). 
There is also evidence that at least one type of control group for RCTs, waiting list, may 
overestimate the effectiveness of therapy (Gold et al., 2017). Additionally, most research 
looks at short to medium term outcomes, which may not adequately capture changes in 
individuals’ lives.  
To date researchers have not been able to definitively define the mechanisms of 
change (i.e. “the steps or processes through which therapy [or some independent variable] 
actually unfolds and produces the change”, Kazdin, 2007, p. 3) for psychological 
interventions, nor ascribe specific weighting or roles to different therapy-specific or 
common factors (Cuijpers, Reijnders, & Huibers, 2019). Indeed, research into mechanisms 
of change in psychological therapy largely focuses on individual therapies, and explores the 
predictive values of individual measured components of their therapy. For instance, a 
review by Lemmens et al. (2016) sought to investigate the mechanism of change of 
therapies for depression, by looking at psychological mediators in various forms of 
psychotherapy for depression. They identified 35 relevant studies, which employed 
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different therapies: CBT was the most frequently researched intervention (examined in 
21/35 studies), followed by third-wave CBT interventions (or components of CBT; 10/35). 
Most factors of the 39 investigated factors were related to the hypothesised processes 
specific to the therapy (studies that looked at CBT focussed on CBT processes as mediators; 
e.g. Negative Automatic Thoughts, Dysfunctional Attitudes, and behavioural factors; whilst 
the studies with interventions that employ Mindfulness focussed on factors relevant to 
this; Rumination, Mindfulness, and Worry). Rumination and Worry can also be considered 
as depression symptomology (or hypothesised mechanism of the disorder). Therapeutic 
Alliance was the only non-symptomology or therapy mechanism-specific factor 
investigated, though this was only considered in 3/35 studies. Individual factors were 
examined few times and found to be significant in few studies; mostly within their own 
modality. The authors concluded that research into the mechanism of change is 
“heterogeneous and unsatisfactory in methodological respect” (Lemmens et al., 2016, p. 
95). 
The difficulty in synthesising this literature may be due to the continued 
exploration into therapy-specific factors, rather than exploring non-therapeutic modality 
specific factor which may affect change across therapies (and/or treatment indications). It 
is important to understand the factors which may explain the mechanism of change in 
psychological therapy, both specific to the therapy, and common for all therapies, to 
understand why some therapies seem to work better for some indications, in different 
contexts, and why not all individuals benefit from the same therapies in the same way. 
Candidate non-therapeutic modality specific factors that may be argued to 
influence outcome of psychological interventions can be classed broadly into four groups; 
contextual (e.g. catharsis from the formal opportunity to discuss difficult experiences, using 
formulation within theoretical frameworks to reframe experiences; as proposed by 
Rosenzweig, 1936); therapist-specific (e.g. therapists’ personality, warmth, unconditional 
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positive regard, treatment fidelity, attachment style, and biases or beliefs); client-specific 
(individual social/environmental factors, engagement, motivation and readiness for change, 
adherence to treatment, particular difficulties/treatment needs, attachment style and 
personality); and finally within the therapist-client relationship (e.g. therapeutic alliance), 
which is influenced by the other factors (and the relationship between them, e.g. the 
therapist and client’s attachment styles or personality traits). 
Personality 
Personality is one of the primary individual differences, in the ways that people 
think, feel and act (McCrae & John, 1992). An individual’s personality is made up of traits; 
"stylistic and habitual patterns of cognition, affect, and behaviour " (Emmons, 1989, p. 3). 
Personality traits have been shown to be linked to wide-ranging outcomes and life 
experiences, such as individuals’ happiness, health, work satisfaction and performance, 
quality and satisfaction with close relationships, as well as the formation of identity (Ozer & 
Benet-Martinez, 2006).  
There are a number of ways by which personality may be hypothesised to influence 
change in psychological therapy and therefore affect treatment outcomes. An individual’s 
propensity for change in therapy may be influenced by their engagement and adherence 
with treatment. Considering traits from the five-factor model (FFM; Costa & McCrae, 1990, 
further described in the Systematic Review, p. 17), Conscientiousness has been linked with 
adherence to treatment in physical health settings (e.g. Cheung, LeMay, Saini, & Smith 
2014). Openness to Experience relates to individuals’ flexibility in thought, experience, and 
beliefs, which may increase their engagement in therapy. In addition, Openness to 
Experience has also been linked to greater use of more adaptive, flexible coping response 
in response to stress (Lee-Baggley, Preece, & DeLongis, 2005), which may facilitate the 
assimilation of new coping strategies in therapy. Agreeableness has been linked to the 
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development of therapeutic alliance, which has been shown to be related to outcome and 
adherence to treatment (e.g. Martin, Garske, & Davis, 2000). 
Before we test hypothesised roles for personality in the mechanism of change in 
psychological therapy, it is important to ascertain whether personality is in fact a significant 
predictor of treatment outcomes. From a clinical perspective, if personality were to be 
found to be a significant predictor of outcome, this could form a useful tool for clinicians in 
the assessment and treatment planning phase. As personality would form only one of 
many individual factors which may be part of influencing the mechanism of change and 
therefore response to therapy, it would not serve to denote which individuals will benefit 
from, and should therefore have access to, certain treatments. Instead, it could be useful in 
considering whether certain adaptations can be made to facilitate clients’ engagement in 
therapy, as well as help focus and tailor aspects treatment. 
A previous study by Bucher et al. (2019) explored the association between 
personality and treatment outcomes, but no studies to date have looked at whether 
personality traits are significant predictors of outcome. To aid in this pursuit, this thesis 
portfolio presents two studies; a systematic review that sought to establish whether 
personality traits significantly predict outcomes of psychological interventions; and an 
empirical project that sought to establish whether there is a relationship between 
personality traits and treatment outcomes in a forensic mental health services. 
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Chapter 2: Systematic Review 
The following paper has been prepared in accordance to Personality and Individual 
Differences, author guidelines can be found in Appendix A. Two exceptions have been 
made for ease of reference: table captions are presented above tables, and subheadings 
have been formatted to match the format of the portfolio. The Supplementary Materials 
are found at the end of the chapter for the readers’ convenience. 
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Introduction: Clients’ personality traits have been hypothesised to impact the course and 
outcome of psychological interventions. Their predictive value has been investigated in 
treatment effectiveness studies, though no systematic review has been undertaken to 
synthesise this literature. The present study sought to establish whether five-factor model 
(FFM; Costa & McCrae, 1990) personality traits predict clinical and psychosocial outcomes 
of psychological interventions.  
Method: A systematic search of five databases identified seven studies that met the 
inclusion criteria. A narrative synthesis was undertaken to synthesise the data. 
Results: Few significant predictor relationships between FFM traits and outcomes were 
found. Neuroticism, Extraversion and Openness to Experience were found to significantly 
predict outcomes for symptom severity in one study each, and Agreeableness significantly 
predicted treatment completion. Conscientiousness was found to be a significant predictor 
for abstinence (from gambling), coping skills, symptom severity, remission, and treatment 
completion, however it was not found to be a significant predictor in over two thirds of 
outcomes investigated.  
Conclusions: Few studies have investigated the predictive role of FFM traits for 
psychological intervention outcomes, with only one study identified per indication and only 
cognitive-behavioural interventions represented. Further research into the role of client 
personality traits and other idiosyncratic variables is warranted to understand the 
mechanism of change. 
PROSPERO registration number CRD42018110609 (Registered 25th September 2018) 
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 Introduction 
Personality is one of the primary ways in which individuals differ, driving the ways 
that people think, feel and act (McCrae & John, 1992), and is a candidate idiosyncratic 
variable that has been hypothesised to form part of the mechanism of change in therapy, 
affecting the way individuals respond to therapy (e.g. Costa Jr., 2008; Widiger & Presnall, 
2013). Significant recent research has explored the connections between normative 
personality traits and various clinical outcomes/variables. The most researched 
dimensional model, the five-factor model (FFM; Costa & McCrae, 1990), was developed 
through lexical analysis of personality terms that occur in different languages. The five 
traits have been shown to be generalised across cultures (e.g. Terracciano & McCrae, 2006), 
with similar changes across lifespan seen, suggesting a common cross-cultural maturation 
in personality. 
The FFM has been shown to be a useful tool in describing individuals’ adaptive and 
maladaptive traits. Multiple iterations of the model have been developed with slight 
differences (e.g. Goldberg, 1992; Saucier, 1997), though the original FFM (Costa & McCrae, 
1990), which has the broad consensus of literature, consists of five personality trait 
domains: Neuroticism, Extraversion, Openness to Experience (hereafter “Openness”), 
Agreeableness and Conscientiousness. In the most widely used measure for FFM, NEO 
Personality Inventory – Revised (Costa & McCrae, 1992), each trait is made up of six facets.  
Neuroticism represents a “tendency to experience psychological distress”. 
Extraversion encompasses individuals’ level of sociability and activity, as well as their 
propensity for positive emotions and pleasure. Openness refers to a person’s level of 
imagination, interest in arts, and flexibility in thought, experience, and beliefs. 
Agreeableness is a trait that refers to an individual’s disposition in interpersonal relations; 
how trusting, sympathetic and cooperative they are. Conscientiousness represents how 
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organised and diligent individuals are, as well as how much controlled effort they put into 
their actions (Costa & McCrae, 1992). 
FFM traits have been found to be related to, and even predict, many experiences in 
life, such as happiness, health, work satisfaction and performance, quality and satisfaction 
with close relationships, as well as the formation of identity (Ozer & Benet-Martinez, 2006). 
FFM traits have also been shown to predict the development of clinical disorders. A profile 
of high Neuroticism, low Conscientiousness, low Agreeableness, and low Extraversion has 
been shown to be associated with symptoms of various clinical disorders (Malouff, 
Thorsteinsson, & Schutte, 2005). Multiple longitudinal studies have shown that high 
Neuroticism and low Extraversion also predict the development and chronicity of both 
major depression and anxiety disorders (e.g. Clark, Watson, & Mineka, 1994; Kendler, Kuhn, 
& Prescott, 2004; Krueger, Caspi, Moffitt, Silva, & McGee, 1996). There is some evidence 
that low Openness is also associated with clinical disorders however the effect sizes are 
small compared to the other traits (Malouff et al., 2005). 
The stability of personality traits has been the subject of longstanding debate. For 
the purposes of this review, personality traits are considered to be temporally stable 
constructs, following the five-factor theory (a theory created by the FFM authors, 
explaining how personality is developed and operates, McCrae & Costa, 1996). For 
discussion about the ongoing debate in the field of personality research regarding the 
stability and measurement of traits see the Discussion chapter (p. 131). 
Personality Traits and Response to Treatment 
Previous studies have explored the effect of personality traits on treatment 
outcome in different areas, finding that the role of personality traits, as well as the 
consistency of findings, has varied. In research considering treatment for physical health 
conditions, Neuroticism has been associated with medical non-compliance to asthma 
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treatment, and Conscientiousness with compliance (Cheung, LeMay, Saini, & Smith 2014). 
Similarly, lower Extraversion, Agreeableness, and Conscientiousness, but higher 
Neuroticism, suggested poorer treatment outcomes for depression in patients with acute 
coronary syndrome (Kim et al., 2016). In the field of substance dependence, however, 
research has painted apparently conflicting results. For example, with regards to the 
likelihood and imminence of relapse, researchers have shown significant associations with 
higher Neuroticism and lower Conscientiousness (Bottlender & Soyka, 2005), low 
Agreeableness and high Extraversion (Finn & Robinson, 2012), as well as with no FFM traits 
(Muller, Weijers, Boning, & Wiesbeck, 2008).  
A recent meta-analysis by Bucher, Suzuki, and Samuel (2019) was the first to 
systematically review the association (i.e. observed correlation) between FFM traits and 
mental health treatment outcomes. This included both psychological and 
psychopharmacological interventions, though due to heterogeneity of the studies they 
were unable to undertake separate analysis for different treatments. Whilst using FFM as 
the framework to organize personality trait measures, they included studies that used any 
personality measures, including those that were based on different dimensional personality 
models. They sorted them into corresponding FFM domains according to their 
developmental and theoretical constructs, and following a coding of measures used by 
Roberts et al. (2017; in a systematic review of the change in traits following intervention). 
They found significant associations between FFM traits and treatment outcomes, most 
notably with more favourable outcomes being associated with lower levels of Neuroticism 
and higher levels of Extraversion, Agreeableness, Conscientiousness, and Openness. 
Moreover, they found that Agreeableness was positively associated with therapeutic 
alliance, whilst Conscientiousness was positively associated with greater abstinence from 
substances following treatment. When undertaking moderator analyses, they showed that 
the personality measure used had a significant impact on outcomes, including in studies 
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that had employed more than one measure, suggesting that the constructs being assessed 
by non-FFM measures were not equivalent to the FFM traits.  
The present study sought to build on Bucher et al.’s (2019) review by considering 
the predictive role of FFM traits, including in relation to other idiosyncratic client-specific 
variables, for the outcomes of psychological interventions, specifically. The review will 
attempt to reduce heterogeneity of studies, compared to Bucher et al. (2019), by adopting 
a more restrictive definition of measurement of the FFM (only adopting studies that have 
used established measures for the original FFM framework, as outlined below). 
Additionally, the present review will aim to increase external validity, by focussing on 
empirically supported psychological therapies; including studies that employed 
interventions which are recommended by UK National Institute for Health and Care 
Excellence (NICE) guidelines (made on the basis of systematic reviews of available 
evidence) for the target clinical disorder. In doing so, the study will increase our confidence 
in conclusions that identified variances can be attributed to differences in personality, and 
different psychological intervention frameworks.  
Aims and Objectives 
The aims of this review are to establish whether FFM personality traits predict 
outcomes of psychological interventions, and the magnitude of any findings. In particular, 
does the presence of higher or lower levels of FFM traits show specific patterns of effects, 
and are there specific patterns according to treatment indication, type of psychological 
intervention and specific outcomes? 
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 Methods 
Search Strategy and Terms 
A systematic search was conducted using five electronic databases: MEDLINE 
Complete (via EBSCO), PsycINFO (via EBSCO), CINAHL Complete (via EBSCO), PsycARTICLES 
(via EBSCO) and Scopus, in June 2020. Prior to embarking on this systematic review, the 
Cochrane Collection and Prospero were also checked for any prior reviews in this subject 
area. The full search strategy is available in Table 10 in the Supplementary Material. Search 
terms included variants of FFM (i.e. big five, big 5, five factor model, five factor personality 
model or neuroticism extraversion openness), psychological intervention (i.e. therapy, 
intervention, psychotherapy or treatment) and established FFM measures (as listed in Table 
1 below; IPIP, international personality item pool, big five mini-marker, big five aspect, 
neuroticism-extraversion-openness, neo personality inventory, neo-ffi, neo five-factor 
inventory, neo-pi-r or big five inventory), as well as relevant index terms.  
Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria for the present review is summarised in Table 1. 
No restrictions were placed on publishing date, presence of comorbidity, or edition of the 
diagnostic manual used. The psychological interventions recommended by the relevant 
NICE guidelines are listed in Table 11 in the Supplementary Materials. For clinical disorders 
with no associated NICE guidance, recommendations made by the most recent published 
Cochrane Review were used (e.g. for pathological gambling; Cowlishaw et al., 2012). If 
studies investigated several treatments, only NICE guidelines recommended interventions’ 
data would be extracted. Studies could include medication intervention, however had to 
analyse and report separate outcomes for each psychological therapy. Whilst focusing on 
the predictor relationship, association (i.e. correlation or difference in means, reporting M, 
SD, and statistical significance) of FFM traits for groups based on outcomes, and mediator  
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Table 1. Review Inclusion and Exclusion Criteria 
Inclusion Exclusion 
 Primary peer reviewed research including 
doctorate-level dissertations 
 Non-English language 
Population 
 Target difficulty associated with a formal 
clinical diagnosis 
 Target difficulty subthreshold for clinical 
diagnosis 
 Diagnosed following a recognized 
diagnostic manual 
 Diagnosis not established 
Comparator: Five-Factor Model (FFM; Costa & McCrae, 1990) 
 Assessed FFM personality traits  Other dimensional personality models 
 Investigated at least one full FFM domain  
 Assessed using one of the following 
established measures for the FFM: 
 Only individual facets investigated 
 Domains that are constituted of an 
aggregate of facets, deviating from  
o NEO Personality Inventory – Revised 
(Costa & McCrae, 1992) 
original measure  
 Other measures that measured an  
o NEO Five-Factor Inventory (Costa and 
McCrae, 1992) 
altered FFM (i.e. not Neuroticism, 
Extraversion, Openness to Experience, 
Agreeableness, Conscientiousness). o Big Five Aspect Scales (DeYoung, 
Quilty, & Petersen, 2007) 
o Big Five Inventory (John, Donahue, & 
Kentle, 1991) 
 
o International Personality Item Pool for 
NEO-PI-R (IPIP-NEO-120, Johnson, 
2014; Maples, Guan, Carter, & Miller, 
2014; IPIP-NEO-300, Goldberg, 1999) 
 
Intervention 
 Established, evidence-based formal 
psychological therapy, recommended by 
NICE guidelines, for difficulties associated 
with the formal clinical diagnosis of the 
sample 
 Interventions that deviated from the 
standard application of the therapy 
 Psychological intervention part of 
multimodal treatment where effects 
could not reliably be attributed to the 
psychological therapy 
 Combined participants that received 
different interventions into groups 
 All participants in an analysed group 
received the same treatment 
Outcomes 
 Clinical or psychosocial outcomes, 
assessed by valid measures or events. 
 
 Relationship between baseline FFM trait 
and post-treatment outcome 
 
 Predictor/prognostic relationship 
investigated and reported 
  
 
or moderator relationships were also extracted and reported. Where studies met inclusion 
criteria, but outcomes were not reported in a way that allowed reliable extraction, the 
authors of the study were contacted to request additional data. 
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Study Selection and Data Extraction 
The results of the outlined database searches were transferred to Covidence 
systematic review software (Veritas Health Innovation), for ease of systematic sorting and 
duplicates were removed. The titles and abstracts were screened for potential eligibility by 
the first author (AS). Next, all full text articles were screened by AS, and the included 
studies were screened by a second reviewer (NT) in relation to the outlined inclusion 
criteria. Data extraction was completed by AS using DistillerSR software (Evidence Partners, 
Canada), with a pre-defined data extraction form that was piloted on an included study.  
Quality and Risk of Bias Assessment 
The Downs and Black checklist (i.e. D&B; Downs & Black, 1998), was used to assess 
the methodological quality and risk of bias of the included studies. The D&B can be used to 
assess the quality of both randomized and non-randomized studies, and was reported as 
one of the most useful tools for the assessment of methodological quality in a systematic 
review by Deeks et al. (2003). It includes 27 questions (yes = 1, no/unable to determine = 0), 
covering: Reporting, Internal Validity (Bias and Confounding), External Validity, and Power. 
For the present review the final question on Power was modified to two questions: (a) 
whether power analysis was reported to have been undertaken, and (b) whether the study 
had sufficient power to detect a moderate significant effect (rated as above). A copy of the 
checklist can be found in Appendix B. Study registration information and additional 
published reports were checked for additional information (where relevant and available). 
Quality assessment was done by AS and NT, blind to the other reviewer’s ratings, and any 
disagreements were discussed and where needed resolved by a third reviewer (PB).  
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Synthesis Approach 
The study designs and analysis methods used in the studies were too 
heterogeneous and meta-analysis was not appropriate, so the review employed a narrative 
synthesis. The following variables were coded to allow group synthesis: study design, 
patient status (inpatient vs. outpatient), intervention, FFM domains investigated, outcome 
investigated. Effect-direction plots (adapted from Thomson & Thomas, 2013) were created 
from cross-study synthesis, to provide visual summary of effect direction for the role of 
FFM traits in predicting multiple outcomes across the included studies. Categories of 
outcome variables were also synthesised separately according to type of treatment and 
indication to account for confounding variables and determine differences between these. 
 Results 
The electronic database search identified 2055 articles, after duplicates were 
removed. Figure 1 illustrates the study selection process in a PRISMA flow diagram (Moher, 
Liberati, Tetzlaff, & Altman, 2009). A large amount of studies explored the role of traits in 
predicting outcomes in physical health settings (e.g. physical health medication monitoring). 
The reference lists of the excluded systematic reviews and book chapters, as well as those 
of included studies, were screened for any relevant studies; no new eligible studies were 
identified this way. The reasons for exclusion at full-text screening are illustrated in Table 2. 
There were no disagreements about study inclusion between the two reviewers.  
Two studies, Lammers, Vroling, Ouwens, Engels, and van Strien (2015) and Vroling, 
Wiersma, Lammers, and Noorthoorn (2016), used the same sample and were combined for 
extraction. The final participant sizes differed slightly between the two reports with regards 
to treatment completion and drop out, however this did not change the results. A further 
article, Deumens, Noorthoorn, and Verbraak (2012), used a subsample from this study 






(n = 546) 
Records excluded following 
inclusion criteria 
(n = 1926) 
 
Full-text articles excluded 
according to inclusion criteria 
(n = 121) 
 
Records identified through 
database searching 
(n = 2601) 
 
Scopus = 1910 
PsycInfo = 412 
CINAHL = 124 
MEDLINE = 95 
PsycArticles = 60 
Full-text articles assessed for 
eligibility 
(n = 129) 
Records screened against 
title and abstract 
(n = 2055) 
Studies included in narrative 
synthesis 
(n = 7) 
Articles from the same study 
combined 
(n = 2) 
 
Additional records identified 
from studies’ reference lists  
(n = 0) 
Figure 1. PRISMA Diagram of Study Inclusion 
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Table 2. Exclusionary Details 
Reason for Exclusion (N = 2047) 
Not applicable research (excluded at first stage of screening) 1926 
Study design 
 Different intervention groups not separated for analysisa  12 
Not post-treatment 10 
Not primary research (review, book chapter, poster) 10 
No intervention 6 
Partially duplicate sample of included study (not possible to combine) 1 
Indication 
 Target difficulty not from diagnosable clinical disorder 12 
Intervention 
 Not NICE guideline-recommended psychological intervention 20 
Intervention not psychological 10 
Multimodal treatment or not standard application of intervention 9 
Comparator 
 Not established/included FFM measure used to assess personality 6 
Not FFM dimensional model 5 
Outcomes 
 FFM personality traits investigated as treatment outcome 8 
Only investigated facets of FFM personality traits 4 
No statistical outcomes reported (or supplied upon contact) 4 
Outcomes not psychosocial (i.e. neurocognitive) 1 
Not predictor relationship (i.e. only association, mediator, or 
moderator) 1 
Only indirect role of FFM trait investigated 1 
Study did not investigate outcomes of treatment  1 
a In some cases this included a non-NICE recommended treatment. 
 
this was. They investigated similar outcomes but with slightly different constructs, with 
conflicting results. It was not possible to meaningfully combine the data from this article; 
therefore, it was excluded following Cochrane Handbook guidance (Lefebvre et al., 2019, 
Section 4.6.2). Authors of two further relevant studies were contacted to ask for additional 
information to meet inclusion criteria. One author did not respond, and the second 
responded but the information supplied did not match inclusion criteria, therefore neither 
study could be included. The descriptive statistics of the included studies are shown in 
Table 3 and a summary of their characteristics is presented in Table 4. 
  
 27 
Table 3. Descriptive Statistics of Included Studies 
Total N (% female) 497a (71.64)b 
Median publication year 2013 
Primary diagnoses Binge eating disorder 
Bulimia nervosa 
Chronic fatigue syndrome 
Eating disorder not otherwise specified (bulimic subtype) 
Mood disorder (with psychotic features) 
Pathological gambling 
Psychophysiological insomnia 
Psychotic disorder not otherwise specified 
Social anxiety disorder 
Schizophrenia spectrum 
Patient status Outpatient (100%) 
Intervention Cognitive Behavioural Therapy (CBT) (4) 
CBT augmented by d-cycloserine or placebo (1) 
CBT for insomnia (1) 
Internet-based CBT for bulimia nervosa (1) 
Modal treatment duration 12 weeks 
Modal follow-up time 1 yearc 




Coping skills (3) 
Quality of Life (2) 
Remission (2) 
Symptom severity and improvement (10) 





Note. Unless otherwise specified, the number in brackets indicates number of studies.  
Abbreviations: NEO-PI-R, NEO Personality Inventory–Revised (Costa & McCrae, 1992), NEO-
FFI, NEO Five-Factor Inventory (Costa and McCrae, 1992). 
a N for Lammers et al. (2015) and Vroling et al. (2016) is from the latter. Final analysed N 
from Beauchamp et al. (2013) in unclear. b From 6 of 7 studies as not reported for analysed 
sample in Beauchamp et al. (2013). c From four studies that had a follow-up.
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Table 4. Summary of Characteristics of Included Studies 
Reference Na (% 
female) 
Diagnoses Intervention type and 
manual (or contents) 
















CBT (group)  
 
Manual: Lecomte, 




Duration: 24 Sessions 
of either treatment, 




Delivered by: 2 
therapists (degrees in 
occupational therapy, 
nursing, psychology), 
















Skills Training for 
Symptom 
Management 


















Marcus, and Wilson 
(1993) 




Delivered by:  
1 psychologist,  










 Eating disorder 
pathology 
 Body dissatisfaction 
 Body mass index 
 Demographics: 
education, age  
 Level of depression 
and psychopathology  




Table 4 continued 
Reference Na (% 
female) 
Diagnoses Intervention type and 
manual (or contents) 
















Internet-based CBT for 
bulimia nervosa (ICBT) 
 
2 Forms of ICBT: with 
therapist support via e-
mail (BIB-ICBT; Fairburn, 
Cooper, & Shafran, 2003) 
and online interaction 
with therapists (Salut BNd) 
Duration: 24 weeks  
(1-year follow-up) 
 
Delivered by: 3 
































Contents: stress, gradual 
activity and sleep 
management and 
cognitive therapy 
Duration: 12 x 2-hour 
sessions every two 
weeks 
 
Delivered by:  4 
psychologists, trained by 

























stimulus control, cognitive 



















Table 4 continued 
Reference Na (% 
female) 
Diagnoses Intervention type and 
manual (or contents) 
Intervention Format Settings Study design Investigated predictor 
variables (non-FFM) 





 Social anxiety 
disorder 
CBT (group; augmented 
by d-cycloserine or 
placebo) 
 
Manual: Hofmann and 
Otto (2008) 
Duration: 12 x 2.5Hour 
weekly sessions 
 
Delivered by: 2 therapists 
(profession not reported), 

















 Social anxiety 
symptom severity 
 Depressive symptom 
severity 
 Comorbidity 










CBT for insomnia  
(CBT-I) 
 
Manual: Morin and 
Espie (2003) 
Duration: 6 x weekly 
sessions, followed by 1 
session after 1 and 3 
months 
 











 Cognitive coping  
 Lack of social support 
Note. Bold indicates predictor variables other than FFM, that were significant. Further details about non-FFM predictor findings are shown in Table 12 in 
Supplementary Material. 
a Only data for interventions that met the inclusion criteria is reported. b It is not clear what N was used for the final analysis in Beauchamp et al. (2013). 
Additionally, % female not reported for analysed sample. c From Vroling et al. (2016), larger sample as also analysed dropout. d Available from 
http://www2.salut-ed.org/demo/
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Quality Assessment Rating 
The quality assessment ratings of the included studies are presented in Table 5. All 
studies were second-rated, with moderate initial agreement (Cohen’s κ = .65, 95% CI [.31–
.98], p > .001). Studies were included in the synthesis regardless of rating score. Three of 
the included studies were articles which presented additional/secondary analyses of 
outcomes from studies, with specific criteria used to include participants in these analyses 
and/or separate participants into groups (Beauchamp, Lecomte, Lecomte, Leclerc, & 
Corbière, 2013; Lammers et al., 2015; Smits et al., 2013). Due to this, as well as the 
inclusion criteria for the present review limiting extraction to relevant interventions, the 
sample sizes for Beauchamp et al. (2013) and Lammers et al. (2015) were smaller than the 
original study sample. With the exception of Smits et al. (2013), it was not possible to 
determine whether studies had sufficient power to detect significant effects for the 
outcomes measured. All included studies employed CBT-based interventions. Five studies 
reported that their interventions followed a manual or protocol (listed in Table 4), though 
no studies assessed treatment fidelity explicitly. 
Table 5. Downs and Black Quality Assessment Ratings for the Included Studies 





Power Total Bias Confounding 
(n = 11) (n = 3) (n = 7) (n = 6) (n = 2) (n = 29) 
BEA2013 7 3 6 2 0 18 
LAM2015 & 
VRO2016 9 3 5 4 0 21 
LEV2020 8 1 5 5 0 19 
POP2013 7 1 5 3 0 16 
RAM2013 10 3 4 4 0 21 
SMI2013 9 2 7 5 2 25 
VAN2015 10 3 4 3 0 20 
Note. Study ID: First three letters of first author surname and year of publication. 
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Treatment outcomes 
The outcomes investigated in the included studies were pooled by category for 
synthesis. Table 6 presents the outcomes investigated in each study and the measures used. 
The findings for the associations (i.e. seen correlations between baseline trait scores and 
treatment outcomes, or differences in baseline trait means between groups, e.g. 
completers and non-completers) for each trait are presented in Table 7. The findings for 
the predictor role of each trait for treatment outcomes (analysed by regression or multi-
level modelling), are presented in Table 8. The statistical outcomes relating to these 
findings are portrayed in Table 12 in the Supplementary Materials, including which other 
(non-FFM) variables were significant predictors for each outcome.
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Table 6. Outcomes Investigated in Each Study and the Measures Used, Organised by Outcome Category 
Study ID Outcome Outcome measures used Description 
Abstinence 
RAM2013 Relapse Two episodes of gambling during 1-year follow-up 
Quality of Life (QoL) 
POP2013 Improvement in Mental QoL  36-item Short Form Health Survey (SF-36; Ware & 
Sherbourne, 1992) 
Mental QoL questions 
 Improvement in Physical QoL SF-36 Physical QoL questions 
Coping Skills 
BEA2013 Active coping Cybernetic Coping Scale (CCS; Edwards & Baglioni, 1993) Active coping questions 
 Passive coping CCS Passive coping questions 
POP2013 Acceptance Illness Cognition Questionnaire (Evers et al., 2001) Acceptance subscale 
Symptom Severity and Improvement 
BEA2013 Psychosis symptomology Brief Psychiatric Rating Scale–Expanded (BPRS-E; Lukoff, 
Nuechterlein, & Ventura, 1986) 
Total 
 Psychosis positive symptoms BPRS-E Positive symptoms 
 Psychosis negative symptoms BPRS-E Negative symptoms 
LAM2015 Binge eating pathology Eating Disorder Inventory (EDI-1; Garner, Olmstead, & 
Polivy, 1983) 
Bulimia subscale 
LEV2020 Eating disorder symptomology Eating Disorder Examination Questionnaire, version 4 
(EDEQ; Fairburn & Beglin, 1994) 
Change in total score 
 Presence of binge eating EDEQ Item 17 (binge eating episodes) 
 Frequency of binge eating EDEQ Item 17 (binge eating episodes) 
POP2013 Fatigue severity Checklist Individual Strength (Vercoulen et al., 1994) Fatigue severity subscale 
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 Table 6 continued 
Note. Study ID: First three letters of first author surname and year of publication. 
a Same sample at Lammers et al. (2015) 
  
Study ID Outcome Outcome measures used Description 
SMI2013 Social anxiety symptom severity Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) Total 
 Social anxiety symptom improvement LSAS Change in total score 
VAN2015 Clinical improvement in insomnia 
symptomology 
Insomnia Severity Index (ISI; Morin, 1993; Morin, 
Belleville, Bélanger, & Ivers, 2011) 
Decrease in ISI score of >7 points 
 
Remission 
LEV2020 Eating disorder remission Structured Eating Disorder Interview (SEDI; de Man 
Lapidoth & Birgegård, 2009) 
Not fulfilling diagnostic criteria  
 Eating disorder remission EDEQ Total within 1SD of community norms 
VAN2015 Insomnia remission ISI Post-treatment ISI <8 
Treatment Completion 
VRO2016
a Drop out  Client or therapist-initiated premature discharge 
RAM2013 Drop out  Client-initiated termination, without discussion with the therapist 
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Table 7. Effect Direction Plot of Association Findings per Five-Factor Model (FFM) Trait 
Outcome  FFM domain 
Category Description Study ID N E O A C 
Abstinence             
Abstinence (gambling)a RAM2013      
Quality of Life (QoL)       
Mental QoL POP2013      
Physical QoL POP2013      
Coping skills       
Active coping BEA2013      
Passive coping BEA2013      
Acceptance POP2013      
Symptom severity and improvement       
Psychosis symptoms total BEA2013      
Psychosis positive symptoms BEA2013      
Psychosis negative symptoms BEA2013      
Fatigue severity POP2013      
Insomnia symptomology VAN2015      
Remission             
Insomnia remission VAN2015      
Treatment completion             
Completiona VRO2016b      
Completiona RAM2013      
Note. Study ID: First three letters of first author surname and year of publication. 
Abbreviations: N, Neuroticism; E, Extraversion; O, Openness to Experience; A, 
Agreeableness; C, Conscientiousness. 
Effect direction:  = positive association,  = negative association,  = no significant 
association. 
Sample size: large  = >120; medium  = 50–120; small  = <50. 
Statistical significance: black arrow = p < 0.01; grey arrow = p < 0.05. 
a Outcomes of Abstinence and Completion have been recoded from the opposite outcome 




Table 8. Effect Direction Plot of Predictor Findings per Five-Factor Model (FFM) Trait 
Outcome  FFM domain 
Category Description Study ID N E O A C 
Abstinence             
Abstinence (gambling)a RAM2013      
Quality of Life (QoL)       
Mental QoL POP2013      
Physical QoL POP2013      
Coping skills       
Active coping  BEA2013      
Passive coping BEA2013      
Symptom severity and improvement       
Psychosis symptoms total BEA2013      
Psychosis positive symptoms BEA2013      
Psychosis negative symptoms BEA2013      
Binge eating pathology LAM2015      
Presence of binge eating LEV2020      
Frequency of binge eating LEV2020      
Eating disorder (ED) symptoms LEV2020      
Fatigue severity POP2013      
Social anxiety (SA) symptom severity SMI2013      
SA symptom improvement SMI2013      
Insomnia symptomology VAN2015      
Remission       
ED remission (diagnostic criteria) LEV2020      
ED remission (community norms) LEV2020      
Insomnia remission VAN2015      
Treatment completion       
Completiona  VRO2016b      
Completiona  RAM2013      
Note. Study ID: First three letters of first author surname and year of publication. Bold 
outcomes had significant predictors other than FFM traits (listed in Table 12). 
Abbreviations: N, Neuroticism; E, Extraversion; O, Openness to Experience; A, 
Agreeableness; C, Conscientiousness. 
Effect direction:  = positive association,  = negative association,  = not significant. 
Sample size: large  = >120; medium  = 50–120; small  = <50. 
Statistical significance: black arrow = p < 0.01; grey arrow = p < 0.05. 
a Outcomes of Abstinence and Completion have been recoded from the opposite outcome 




One study explored abstinence as a treatment outcome. Ramos-Grille, Gomà-i-
Freixanet, Aragay, Valero, and Vallès (2013) investigated the role of FFM personality traits 
in predicting relapse and drop out in patients diagnosed with pathological gambling who 
took part in a protocolised individual CBT programme for pathological gambling. At 1-year 
follow-up, 29% of patients were classed as abstinent. Abstinent patients showed 
significantly lower Neuroticism and higher Conscientiousness than patients who had 
relapsed. Abstinent and relapsed patients did differ significantly in age (t = 2.00, p = .05, 
Cohen’s d = 0.52), with the abstinent group being older, and age showed a significant 
positive correlation to Conscientiousness (r = .30, p < .01) and Agreeableness (r = .29, p 
= .01). Conscientiousness was a sole significant predictor for abstinence vs. relapse (lower 
Conscientiousness predicting dropout), and this effect remained significant after the effect 
of age was controlled. 
Quality of Life 
Quality of Life can be defined as “a comprehensive manifestation of personal well-
being, which impacts not only the life expectancy of the patient but also affects the efficacy 
of comprehensive treatment strategies” (Ma et al., 2018, p. 2). One study investigated 
improvement in Quality of Life (QoL) as a treatment outcome. Poppe, Petrovic, Vogelaers, 
and Crombez (2013) investigated the role of acceptance and Neuroticism in predicting 
change in Mental QoL and Physical QoL of patients with chronic fatigue syndrome following 
group CBT. A significant improvement was found in fatigue severity, Mental QoL, Physical 
QoL as well as acceptance. No significant relationship was found between Physical QoL and 
Neuroticism nor Acceptance. Neuroticism showed a significant positive relationship with 
improvement in Mental QoL, with higher Neuroticism associated with greater 
improvement; however Neuroticism did not remain a significant predictor for improvement 
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in Mental QoL when acceptance was entered into the model. Acceptance accounted for 5% 
more variance, with people with lower acceptance showing greater improvement. 
Coping Skills 
Two studies explored coping skills outcomes. Beauchamp et al. (2013) explored the 
predictive value of FFM traits on active and passive coping skills following group CBT for 
first episode psychosis. Following treatment, 51% of participants showed a reliable clinical 
improvement in active coping (meeting the general population norm). There was no 
reliable clinical improvement seen in passive coping. There was a significant positive 
correlation between active coping and Conscientiousness, and higher Conscientiousness 
significantly predicted improvement in active coping, explaining 14% of variance. There 
were no significant associations between any traits and passive coping. Of note, only 
participants who completed pre-post measures and two-thirds of the sessions or who 
stayed in the control condition were included in the analyses, however it is not clear how 
many were in the CBT intervention (the only intervention extracted for this review), except 
for the linear regression analysis, which included 29 participants. No analyses of any 
differences between the analysed sample and the original full sample were reported. The 
authors alluded to a high level of attrition following treatment completion; therefore it is 
not clear whether the relationship seen between change in active coping and 
Conscientiousness could be impacted by any characteristic differences in traits of the 
sample included for analysis (i.e. completers who also returned post-treatment measures). 
Poppe et al. (2013) found no significant correlation between Neuroticism and 
change in acceptance following CBT for chronic fatigue. 
Symptom Severity and Improvement 
In Beauchamp et al. (2013), 35% of participants showed a reliable clinical 
improvement (a drop of more than 10 items on the BPRS total score) following treatment. 
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No significant associations were seen between the FFM traits and change in overall 
psychosis symptomology, or negative symptoms. A significant negative correlation was 
seen with Agreeableness and positive symptoms, with lower Agreeableness associated with 
greater improvement. None of the traits were significant predictors for symptomatic 
change. 
Levallius, Clinton, Högdahl, and Norring (2020) investigated the role of FFM in 
predicting outcomes from internet-based CBT (ICBT) interventions for bulimic eating 
disorders. Another article which employed the same sample to investigate the role of FFM 
in predicting drop out specifically (Högdahl, Levallius, Björck, Norring, & Birgegård, 2016), 
was not included due to analysing FFM trait facets only. Levallius et al., (2020) analysed 
combined participant data from an RCT of two forms of ICBT (results not yet published, 
pilot study: Högdahl, Birgegård, & Björck, 2013), as they stated that the content of the 
interventions was similar, and they aimed to increase power. Analysis of differences 
between the combined intervention groups were not reported (Högdahl et al., 2016, 
reported that there were no significant differences in drop out between the two ICBT 
groups. The pilot study only employed one form of ICBT). This limits the interpretation of 
the findings.  
Levallius et al. (2020) reported a significant reduction in overall eating disorder (ED) 
symptom severity over time. Openness and Conscientiousness were significant predictors 
of symptom reduction, with higher levels of both predicting greater reduction. With 
regards to binge eating they found that there was a significant reduction in binge eating 
frequency over time. They found that Extraversion significantly predicted presence vs. 
absence of binge eating following treatment, with high Extraversion predicting cessation in 
77% of cases. Personality traits did not predict change in binge eating frequency. 
Similarly, in Poppe et al. (2013) Neuroticism was not significantly associated with, 
and did not predict, change in fatigue severity following CBT for chronic fatigue. 
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In a study exploring the pre-treatment predictors of outcomes following CBT for 
patients with binge eating disorder, Lammers et al. (2015) found a significant reduction in 
both bulimia symptom scores and body mass index. Extraversion was shown to be a 
significant predictor for post-treatment bulimia symptom severity, with higher levels 
predicting greater symptom reduction. 
In a secondary article from an RCT on group CBT augmented by d-cycloserine (DCS) 
and placebo for social anxiety disorder (Hofmann et al., 2013), Smits et al. (2013) 
investigated which factors would predict treatment outcomes and which factors moderate 
outcomes of DCS and placebo augmentation. The DCS and placebo augmented groups were 
combined for analysis of predictors. It can be assumed that the outcomes of the combined 
group can be interpreted reliably, as Hofmann et al. (2013) reported that there were no 
significant differences between the two groups in rates of symptom severity and remission. 
No personality traits were found to be significant predictors of change in social anxiety 
symptom severity, though higher Neuroticism pre-treatment significantly predicted higher 
post-treatment symptom severity. With regards to moderators of outcomes between DCS 
and placebo augmentation, Agreeableness and Conscientiousness were both significant 
moderators, whereby people with high Agreeableness and low Conscientiousness achieved 
greater symptom reduction (and more quickly) with DCS augmentation compared to 
placebo.  
van de Laar, Pevernagie, van Mierlo, and Overeem (2015) investigated predictors of 
remission and improvement in symptom severity following CBT for insomnia (CBT-I) for 
people with chronic psychophysiological insomnia. No personality traits were significantly 
correlated with, nor predicted, improvement in insomnia symptoms. 
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Remission 
Two studies investigated remission as a treatment outcome, whereby participants 
no longer met diagnostic criteria or clinical threshold for the diagnosed disorder. Levallius 
et al. (2020) used two definitions for remission in their study of ICBT for bulimic eating 
disorders. The first was no longer meeting criteria on the SEDI (de Man Lapidoth & 
Birgegård, 2009), for which they found that Openness was a significant positive predictor 
(predicting 83% of cases), for the likelihood of remission. The second definition was 
showing a clinically significant improvement in symptomology (such that their post-
treatment scores fell within 1SD of community population on the Eating Disorder 
Examination Questionnaire, version 4; Fairburn & Beglin, 1994). They found that 
Conscientiousness significantly predicted remission in 74% of cases, with higher 
Conscientiousness increasing remission likelihood. 
van de Laar et al. (2015) found no significant relationships between personality 
traits and remission of insomnia following CBT for insomnia. 
Treatment Completion 
In Ramos-Grille et al. (2013), 48% of patients had completed treatment at 1-year 
follow-up. Patients who completed treatment showed significantly lower Neuroticism and 
higher Agreeableness and Conscientiousness than patients who dropped out. 
Agreeableness and Conscientiousness were significant predictors of completion vs. dropout, 
with low scores on both traits predicting drop out. 
In a further report from the study reported by Lammers et al. (2015), Vroling et al. 
(2016) explored the predictive role of FFM traits for dropout from CBT for bulimic eating 
disorders. They found that treatment completers showed significantly higher 
Agreeableness than those who had dropped out from treatment, and Agreeableness was a 
significant predictor for treatment completion (predicting 80.6% of cases).  
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 Discussion 
This review sought to investigate whether FFM personality traits predict 
psychosocial and clinical outcomes of psychological interventions. Table 9 provides a vote 
count of the results outlined above for predictor roles of FFM traits. Overall, few studies 
were found to have explored this link, and within these, few associations and predictor 
 





N E O A C 
Abstinence 1 (1) 
   
1
Quality of Life a 2 (1) 

    
Coping skills 2 (1) 
   
1
Symptom severity 11 (6) 
     Psychosis (early) 3 (1) 





Eating disorder 1 (1)  1 
Chronic fatigue 1 (1) 

    
Social anxiety a 2 (1) 1
   Insomnia 1 (1) 
    Remission 3 (2) 





Insomnia 1 (1) 
    Treatment Completion a 2 (2) 
  
2 1
Total vote count   21 (7)     
Abbreviations: N, Neuroticism; E, Extraversion; O, Openness to Experience; A, 
Agreeableness; C, Conscientiousness. 
Effect direction:  = positive effect,  = negative effect,  = not assessed. 
Synthesis of multiple outcomes: If >2 outcomes investigated in category: black = >66% of 
investigated outcomes report effect; grey = 34–65%; empty = <33%.  
2 outcomes: black = >50%; grey = <50%.  
1 outcome: black = 100%. Number of outcomes indicated in subscript. 
Total sample size: large  = >120; medium  = 50–120; small   = <50. 
Vote count for predictor role: Trend across outcome categories: red  = significant finding 
in >66% of the investigated outcome categories; orange  = 34–65%; yellow  = <33%. 
Trend overall: large  = >66% of all outcomes report effect; medium  = 34–65%; 
small  = <33%. 
a Outcome with significant predictor other than personality trait (listed in Table 12). 
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relationships were found. With regard to association, personality traits were considered 
against clinical outcomes 59 times with only 11 (18.64%) comparisons showing a significant 
association, whilst predictor roles of traits were investigated in 93 relationships, with only 
12 (12.91%) significant predictors found. 
In the present study, Neuroticism, Extraversion and Agreeableness were each 
found to be a significant predictor in only one outcome category, and Openness in two. 
Neuroticism was a significant negative predictor of symptom severity, specifically for social 
anxiety (Smits et al., 2013). Their finding fits with what was observed by Wolitzky-Taylor, 
Arch, Rosenfield, and Craske (2012; this study was not included in the present review due 
to grouping different treatments for analysis, where one treatment was not a NICE 
guideline-recommended treatment of anxiety [i.e. Acceptance and Commitment Therapy]), 
in another study exploring moderators for treatment outcome for anxiety disorders, 
suggesting that for people with anxiety, higher Neuroticism at the beginning of treatment 
may predict worse outcomes. As Neuroticism is correlated with a number of psychological 
difficulties, including anxiety and depression (Malouff et al., 2005), it may be that those 
with higher Neuroticism exhibited higher pre-treatment symptom severity levels. Smits et 
al. (2013) did not report having undertaken correlation analysis between initial symptom 
severity and Neuroticism scores however, so it is not possible to know if this may have 
been the case for the present sample. 
Extraversion was found to be a significant positive predictor for symptom severity 
and improvement, specifically for binge eating symptoms (improvement in binge eating 
symptoms following group CBT, Lammers et al., 2015; and likelihood of binge eating 
cessation following ICBT, Levallius et al., 2020). Lammers et al. (2015) postulated that being 
more extraverted, perfectionistic, and feeling less ineffective, may help people to engage 
with the process of change required for treatment. Levallius et al. (2020) did not discuss 
the possible reason for Extraversion predicting cessation of binge eating.  
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Agreeableness was found to be a positive predictor of treatment completion, for 
people receiving individual CBT for pathological gambling (Ramos-Grille et al., 2013) and 
group CBT for binge eating disorder (Vroling et al., 2016). It could be that low 
Agreeableness presents a barrier to engagement in treatment and building a therapeutic 
alliance, which in turn could lead to dropout (Hirsh, Quilty, Bagby, & McMain, 2012). 
Openness was a significant positive predictor of improvement in symptom severity 
from bulimia nervosa (Levallius et al., 2020), reaching remission according to one of the 
study’s two measures of remission, whereby participants no longer met diagnostic criteria, 
however not to the extent of being within the range of functioning of a non-clinical 
population, which instead was predicted by Conscientiousness. The positive effect of 
Openness has been seen in other studies looking at binge eating (e.g. Levallius, Roberts, 
Clinton, & Norring, 2016; though not in the other study included for review, Lammers et al., 
2015). The authors postulate that the effect of greater Openness is facilitating engagement 
with intervention. 
In contrast to the other traits, Conscientiousness was found to be a significant 
predictor of outcome in each of the categories investigated, for three indications: gambling, 
early psychosis and binge eating (within binge eating disorder and bulimia nervosa). 
Conscientiousness was a positive predictor for abstinence, as well as treatment completion 
(in participants with pathological gambling, Ramos-Grille et al., 2013, though not in binge 
eating disorder, Vroling et al., 2016), increase in active coping skills (in early psychosis, 
Beauchamp et al., 2013) and improvement in ED symptomology and likelihood of ED 
remission (in binge eating disorder, Levallius et al., 2020). It is possible that the discrepancy 
in prediction findings between the two remission criteria in Levallius et al. (2020) could be 
due to Conscientiousness presenting a greater impact on remission; therefore symptom 
improvement is even larger, bringing participants not only out of the diagnostic criteria 
range, but within non-clinical population means. Indeed, the finding that Conscientiousness 
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was a significant predictor in the most outcome categories fits with the available literature. 
Conscientiousness has shown to be highly correlated with treatment adherence, as well as 
better health behaviours (Hill & Roberts, 2011). It may facilitate improved outcomes 
following treatment by supporting the development of active coping skills, and thereby aid 
with responsivity to treatment. 
The recent meta-analysis by Bucher et al. (2019) investigated the relationship 
between personality traits and treatment outcomes by focusing on the association 
between baseline trait levels and outcomes. Bucher et al.’s study identified a range of 
associations between five-factor personality variables and clinical outcomes from mental 
health treatment (including psychological intervention, psychotropic medication, and a 
combination of these treatments). The present study sought to understand whether some 
of these relationships were predictive of outcome, specifically for psychological 
interventions. In contrast to Bucher et al.’s study, outcome categories were considered 
individually, to account for confounding variables and gain a better understanding of the 
predictive value of FFM traits for different disorders. Furthermore, the included studies 
used analysis methods to identify significant predictors (regression and modelling) that 
allowed them to account for different covariables, to ascertain which of the significant 
associations found accounted for the largest portion of variability in results (and therefore 
predicted outcome). Findings for other variables as predictors were extracted to consider 
the role of personality as a predictor in light of other variables. 
Broadly, it can be said that the findings from the present study show a similar 
pattern as those obtained by Bucher et al. (2019), however the strength and prevalence of 
this relationship is contrasted. Though this review focussed on predictor relationships, 
which Bucher et al. did not review, associations were also extracted, and few associations 
between personality variables and clinical outcomes were obtained. This may be due to the 
difference in included interventions; Bucher et al. looked at a broad range of treatments, 
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and a majority of the included studies employed treatments that were not exclusively 
psychological interventions (i.e. psychological therapies), and these treatments were 
grouped together for meta-analysis. This study focused only on psychological therapies, 
and only those that were empirically supported (as recommended by NICE guidelines). 
Psychological therapy and medication treatment are undeniably different, and may involve 
different processes, which may be influenced by personality in different ways. Indeed, 
when analysing possible moderators, Bucher et al. (2019) found that participants in studies 
that used only medication had significantly stronger associations with Neuroticism (r = -.24) 
compared to those administered both medication and therapy (r = -.04), supporting the 
notion that these treatments involve different processes for individuals. 
It may be that psychological interventions are less, or differently, affected by 
personality traits than non-psychological interventions such as medication regimes. 
Psychological therapy involves more social interaction and engagement by the client than 
undergoing a medication regimen, so different traits may be more important, as well as 
different processes. For example, therapeutic alliance has been shown to be predictive of 
outcomes for psychological interventions (e.g. Martin, Garske, & Davis, 2000). The studies 
included in this review did not explore moderating roles of personality traits in the 
development or impact of other variables such as therapeutic alliance. A study by Hirsh et 
al. (2012; which did not meet inclusion criteria for the present review due to the focus on 
personality being secondary), looked at the role of therapeutic alliance and Agreeableness 
in outcomes of Dialectical Behaviour Therapy for borderline personality disorder, and 
found that therapeutic alliance was a significant predictor of outcome, and Agreeableness 
was a significant moderator for the development of therapeutic alliance (and therefore had 
a significant indirect role in greater treatment outcomes, via larger therapeutic alliance 
improvement).  
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It is also possible that different psychological interventions are affected differently 
by personality traits, which this review had sought to explore. For example, clients with 
higher Conscientiousness may experience greater improvement in more structured 
therapies such as CBT, having greater influence over active engagement with treatment 
elements (Widiger & Presnall, 2012), whilst clients with higher Agreeableness could benefit 
more from therapeutic approaches that have greater focus on process and the therapeutic 
relationship, due to developing greater therapeutic alliance, as discussed above. 
Furthermore, individuals may also respond differently to different delivery formats, such as 
group or individual therapy, depending on their personality profile; for example, group 
therapy could “offset” difficulties of individuals with low Extraversion and Agreeableness, 
leading to greater improvement (Talbot et al., 2003). However, due to limited 
heterogeneity of individual treatments covered, and small sample sizes, Bucher et al. 
(2019), could only investigate moderating differences between type of treatment (i.e. drug 
vs. psychological therapy) rather than specific interventions and delivery formats, and the 
present review only identified studies employing CBT (and there were too few studies to 
separate delivery formats), so it is not possible to consider further whether therapies from 
different theoretical frameworks and delivery formats have different relationships with 
personality traits. Further research into the relationship between personality traits and 
other idiosyncratic variables and outcomes from treatment is needed in further therapeutic 
frameworks, so as to allow for review and comparison between modalities. 
Based on the findings of this review, Conscientiousness appears to be the FFM trait 
with the greatest predictor role for treatment outcomes from psychological interventions. 
However, it was found to be a significant predictor only in less than a third of the outcomes 
investigated in the included studies (as seen in Tables 8 and 9). It is possible therefore that 
FFM personality traits are not a key non-therapeutic modality-specific factor of influence 
for treatment outcomes in psychological intervention, especially when compared to other 
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idiosyncratic variables. Bucher et al. (2019) had also found that the association between 
traits and treatment outcomes was significantly moderated by frequency of treatment 
(with Conscientiousness being more important when treatment sessions were less 
frequent), as well as duration (with greater association with Extraversion, Openness, and 
Agreeableness), and treatment settings (inpatient treatment-recipients showed a negative 
association, whilst outpatients showed a positive association, between Extraversion and 
favourable treatment outcomes). The limited amount of available literature, and therefore 
limited breadth of characteristics in the included studies in the present review (e.g. all 
outpatient, with similar lengths of treatment due to similar therapy used [all CBT-based]), 
meant that it was not possible to consider the moderating role of these contextual factors. 
Other idiosyncratic variables besides personality traits (i.e. client-, context-, therapy-, and 
therapist-specific) may therefore play an equal or more important role than client 
personality traits for outcomes in psychological intervention. Indeed, five of the seven 
included studies explored other client-specific variables as predictors as well as personality 
traits, and they all found that other variables (including baseline severity of 
psychopathology, social embedding, acceptance, psychiatric comorbidity, body 
dissatisfaction and cognitive coping styles) were significant predictors of outcome. Due to 
the heterogeneity of these variables and the measures used to assess them, it was not 
possible to investigate their moderating role for personality traits’ prediction of treatment 
outcomes across studies. It was also not possible to interpret the relationship between 
these variables and personality traits from the included studies, however, their role as 
equal predictors in the final models in the included studies suggests that personality traits 
are not more important than these other variables in predicting the outcomes of 
psychological interventions. 
It may be that the role of FFM traits varies in different presentations; for instance, 
in the present study no FFM traits were found to significantly predict any outcomes for the 
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early psychosis sample. However, it not possible to reliably conclude the predictive value of 
FFM traits due to the sparsity of available research overall, as well as from individual 
indications. Despite using a list of 52 psychological therapies (that are recommended by 
NICE guidelines, as found in Table 11 in Supplementary Material) for inclusion, only studies 
with various forms of CBT ultimately met other inclusion criteria. It was noted that some 
studies that employed NICE recommended psychological interventions had employed the 
interventions with disorders for which they were not the recommended treatment in NICE 
guidelines, and therefore could not be included in the review. Studies also had to utilise a 
sample with a clinical diagnosis which was the indication for treatment. This means that 
studies looking at psychological interventions for subthreshold psychological difficulties 
were not included. It could be argued that this may limit the external validity of the findings, 
however this decision was made to allow for planned comparison between studies (e.g. for 
symptom severity and differences between therapeutic modalities). Despite these 
restrictions from the inclusion criteria, no restrictions were placed on publication year, 
psychiatric diagnosis, or diagnostic manual, and very few studies were identified. Only one 
study was available per indication, and no studies were found for some of the most 
prevalently researched indications, such as depression and generalised anxiety. It would 
therefore appear that the sparsity of available research is a limitation of the evidence base. 
Future Directions for Research 
This review provides a systematic overview of the available evidence of the 
predictive role of FFM traits for outcomes of psychological interventions. It is apparent that 
there is a lack of research into the predictive and mediating/moderating role of personality 
traits for treatment outcomes, in particular for treatment approaches that have an 
established evidence base. Research which furthers our understanding of factors that 
contribute towards differential effectiveness of psychological treatments could 
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meaningfully encompass an enhanced focus on the measurement of personality variables, 
ideally using well validated and common tools such as the NEO-PI-R. We would encourage 
any clinicians and researchers who gathered personality measures as part of their battery 
of measures in treatment, to analyse and publish their outcomes, so as to add to the 
available evidence base. 
As well as further research into the predictive and moderating role of personality 
traits for treatment outcomes, we recommend research into the predictive role of other 
idiosyncratic client variables, especially in conjunction with personality, so that their 
predictive value may be compared. This would allow researchers to begin hypothesising 
about the overlap, or procedural relationship, between these variables. To allow this to 
happen, we echo recommendations previously made in conclusions of reviews (e.g. 
Cuijpers, 2019), that researchers should adopt a set of recommended standardised 
measures, to allow for later reviews to meaningfully and reliably synthesise their findings.  
From a clinical standpoint, whilst the present study has not established a clear 
predictive role for personality traits for outcomes from psychological interventions, past 
literature points to their usefulness in treatment planning and psychological formulation–at 
least in certain contexts. The use of personality measures may assist treatment planning, 
specifically consideration of adaptations and facilitators for clients’ success in therapy. For 
instance, lower Conscientiousness levels, and particular facets of it, may be useful for 
considering whether clients may need more support to facilitate their engagement, for 
example practical considerations to support homework completion. Agreeableness levels 
may be explored to consider ways to facilitate the development of the therapeutic alliance 
early in the intervention to prevent chances of dropout. 
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Table 10. Details of the Search Strategy 
Fields Search terms 
All included databases 
All fields "ffm" or "big five" or "big 5" or "five factor model" or "five factor 
personality model" or "neuroticism extraversion openness"   
AND 
Abstract "therapy" or intervention or psychotherap* or treatment or 
"therapies"   
AND 
All fields "ipip" or "international personality item pool" or "big five mini-
marker*" or "big five aspect*" or "neuroticism-extraversion-
openness" or "neo personality inventory" or "neo-ffi" or "neo five-
factor inventory" or "neo-pi-r"  or “big five inventory” 













"Five Factor Personality Model" or "neuroticism" or "openness to 
experience" or "agreeableness" or "extraversion" or 
"conscientiousness"; "Psychotherapy"; "NEO Personality Inventory" 
Note. It was later decided that studies using Big Five Mini-Markers to assess five-factor 




Table 11. List of Psychological Interventions Recommended by the National Institute for 
Health and Care Excellence (NICE) Guidelines and Included in the Review 
Intervention Psychiatric Diagnosis 
Acceptance and commitment therapy 
(ACT) 
Chronic pain 
Adolescent-focused psychotherapy for 
anorexia nervosa (AFP-AN) 
Eating disorder (anorexia nervosa; AN) 
Anorexia-nervosa-focused family therapy 
for children and young people (FT-AN) 
Eating disorder (AN) 
Applied relaxation Generalised anxiety disorder (GAD)a 
Arts therapies Psychosis 
Attachment-based family therapy Depression (in children and young people; 
i.e. CYP) 
Behavioural activation (BA) Depression 
Behavioural couples’ therapy (BCT) Bipolar disorderb, depression, substance 
abuse (drugs and alcohol) 
Behavioural support for smoking cessation Substance abuse/dependence (smoking) 
Behavioural therapy (BT) Antisocial personality disorder (PD), 
substance abuse/dependence (alcohol) 
Binge-eating-disorder-focused guided self-
help programme 
Eating disorder (binge eating disorder; 
BED) 
Brief strategic family therapy (BSFT) Alcohol misuse in CYP 
Bulimia-nervosa-focused family therapy 
(FT-BN) 
Eating disorder (bulimia nervosa; BN) 
Bulimia-nervosa-focused guided self-help 
programme 
Eating disorder (BN) 
Cognitive behavioural therapy (CBT) Antisocial PD, attention-deficit 
hyperactivity disorder (ADHD), bipolar 
disorder, body dysmorphic disorder (BDD), 
chronic fatigue, chronic pain, depression 
(inc. CYP, 12–18 years), gambling disorderc, 
GAD, obsessive compulsive disorder (OCD), 
panic disorder, psychosis, social anxiety 
disorder, substance abuse (drugs, 
comorbid with depression/anxiety) 
CBT for Insomnia (CBT-I) Insomnia 
Cognitive analytic therapy (CAT)d Borderline PD 
Cognitive processing therapy Post-traumatic stress disorder (PTSD) 
Cognitive stimulation therapy (CST); group Dementia 
Cognitive therapy PTSD 
Computerised CBT (cCBT) Depression, PTSD (trauma-focussed cCBT) 
Counselling Depressione, psychosis (if other treatments 
unavailable) 
Dialectical behaviour therapy (DBT)   Borderline PD 
 61 
Table 11 continued 
Intervention Psychiatric Diagnosis 
Eating-disorder-focused CBT (CBT-ED) Eating disorder (AN, BED, BN) 
Eating-disorder-focused focal 
psychodynamic therapy (FPT) 
Eating disorder (AN) 
Exposure and response prevention (ERP) BDD, OCD 
Eye movement desensitisation and 
reprocessing (EMDR) 
PTSD 
Family intervention Bipolar disorder, psychosis 
Family therapy Depression in CYP (5–11 years) 
Functional family therapy (FFT) Alcohol misuse in CYP 
Interpersonal therapy (IPT) Bipolar disorder, depression (adults and 
CYP) 
Maudsley anorexia nervosa treatment for 
adults (MANTRA) 
Eating disorder (AN) 
Mentalisation-based therapy (MBT) Personality disorders 
Mindfulness-based cognitive therapy 
(MBCT) 
Depressionf, personality disorder 
Motivational interviewing Gambling disorder 
Multidimensional family therapy (MFT) Alcohol misuse in CYP 
Multisystemic therapy (MST) Alcohol misuse in CYP, oppositional defiant 
disorder, conduct disorder 
Narrative exposure therapy PTSD 
Non-directive support therapy Depression in CYPg 
Parent training programme ADHD, conduct disorder, oppositional 
defiant disorder 
Prolonged exposure therapy PTSD 
Psychodynamic psychotherapy / Short-
term psychodynamic psychotherapy 
(STPP) 
Depressionc, depression in CYP (5–
11years), social anxiety disorder 
Relaxation therapy Anxiety in adults with learning disabilities 
Reminiscence therapy; group Dementia 
Supportive psychotherapy Psychosis (if other treatments unavailable) 
Social and cognitive problem solving Conduct disorder, oppositional defiant 
disorder 
Social learning programme Autism spectrum disorder 
Social network and environment-based 
therapies 
Alcohol dependence and misuse 
Specialist supportive clinical management 
(SSCM) 
Eating disorder (AN) 
Systems integrative family therapy Depression in CYP (5–11 years) 
Therapeutic community Antisocial personality disorder (comorbid 
substance abuse), substance abuse (people 
in prison) 
Trauma-focused CBT (TF-CBT) PTSD 
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Note. Included interventions were all recommended by NICE Guidelines for the listed 
disorders (as of June 2020).  
a For Low intensity GAD: Psychoeducational group, individual non-facilitated self-help based 
on CBT, individual guided self-help based on CBT. b In addition, for bipolar disorder: "Offer a 
structured psychological intervention (individual, group or family), which has been 
designed for bipolar disorder and has a published evidence-based manual describing how it 
should be delivered, to prevent relapse or for people who have some persisting symptoms 
between episodes of mania or bipolar depression." (Recommendation 1.7.4 of the NICE 
clinical guideline on bipolar disorder: assessment and management). c There are currently 
no NICE guidelines for treatment of gambling addiction. Recommendations made by the 
most recent Cochrane Review were used, which found evidence of benefit from CBT 
(Cowlishaw et al., 2012). d CAT was also included as it is held as a recommendation for 
further research in the review of evidence for guidelines for borderline personality 
disorder. e Counselling and short-term psychodynamic psychotherapy for depression: for 
people with persistent subthreshold depressive symptoms or mild to moderate depression, 
only if other treatments were declined. f MBCT only for relapse prevention in people who 
are currently well but have experienced three or more previous episodes of depression. g 5-
11‑year‑olds with mild depression continuing after two weeks of watchful waiting, and 
without significant comorbid problems or active suicidal ideas or plans. 
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Table 12. Study Findings of Significant Five-Factor Model (FFM) Trait Relationships (Association and Predictor) with Treatment Outcomes 
Study ID Treatment Outcome Significant Association  Significant Predictor Other significant predictors 
Abstinence 
RAM2013 Relapse N  (t = 2.33, p = .023, d = .58)b 
C  (t = 3.12, p = .004, d = .89)b 
C  (B = -0.11, p = .01, OR = 0.90,  




Quality of Life (QoL) 
POP2013  Mental QoL N  (r = .27, p < .05)a - Acceptance 
 Physical QoL 
a
 -  
Coping skills 
BEA2013 Active coping C  (r = .379, p = <.05)a C   (R2 = .144, F = 4.709, p = <.05,  











 -  
Symptom severity and improvement 




   
 Psychosis positive symptoms A  (r = .315, p = <.05)a e  





LAM2015 Binge eating pathology - E  (ß = 0.173, t = 2.602, p = .01)f EDI bulimia scale, drive for thinness, 
interoceptive awareness, ineffectiveness, 
perfectionism; SCL-90 depression and total 
LEV2020 Presence of binge eating - E  (b = -0.048, SE 0.022, p = .030)d Baseline symptom severity (EDEQ score) 
 Frequency of binge eating - g  
 Eating disorder symptomology - O  (t = 1.85, p = .034)g 
C  (t = 3.75, p < .001)g 
 





SMI2013 Social anxiety symptom 
severity 
- N  (b = 2.39, SE = .85, p <.01)g Black or African American race; Single; 
initial severity of symptoms (LSAS) 
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Table 12 continued 
Study ID Treatment Outcome Significant Association  Significant Predictor Other significant predictors 
SMI2013 Social anxiety symptom 
improvement 
- g Black or African American race; Single; 
initial severity of symptoms (LSAS) 






LEV2020 Eating disorder remission 
(diagnostic criteria) 
- C  (b = −0.058, SE 0.019, p = .002)d Baseline symptom severity (EDEQ score) 
 Eating disorder remission 
(community norms) 
- O  (b = −0.055, SE 0.023, p = .01)d  








 Drop out A  (F = 0.68, p < .01)b A  (B-weight = -.02, p < .01,  
OR = 0.98, 95% CI [0.96, 0.99])
d
 
Low social embedding; medium level of 
education; EDI bulimia score; and EDES 
anorectic preoccupation and social 
adjustment 
RAM2013 Drop out N  (t = 2.12, p = .037, d = .49)b 
A  (t = 2.43, p = .018, d = .56)b 
C  (t = 2.74, p = .008, d = .64)b 
A  (B = -0.06, p = .04, OR = 0.94,  
95% CI [0.89, 0.99])
d 
C  (B = -0.08, p = .02, OR = 0.92,  




Note. Study ID: First three letters of first author surname and year of publication. All studies investigated all five FFM domains, except Poppe et al. (2013), 
which investigated only Neuroticism. Only significant findings presented. Statistical data reproduced as reported in the papers. No significant moderator 
relationships found. FFM domains: N, Neuroticism; E, Extraversion; O, Openness to Experience; A, Agreeableness; C, Conscientiousness. 
Abbreviations: EDES, Eating Disorder Evaluation Scale (Vandereycken, 1993); EDEQ, Eating Disorder Examination Questionnaire, version 4 (Fairburn & 
Beglin, 1994); EDI, Eating Disorder Inventory (Garner, Olmstead, & Polivy, 1983); LSAS, Liebowitz Social Anxiety Scale (Liebowitz, 1987); SCL-90, Symptom 
Checklist (Derogatis, Lipman, & Covi, 1973).  
Effect direction: △ = positive effect,  ▽ = negative effect,  = no traits with significant association, - = not assessed. 
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Sample size: final sample size (individuals) in intervention group: large  = >120; medium  = 50–120; small  = <50. 
Statistical significance: black arrow = p < 0.01; grey arrow = p < 0.05; - = no statistical results reported. 
Statistical tests: Association: a Pearson correlation between trait and change in outcome from baseline. b Difference in baseline trait score means (t-test or 
univariate ANOVA) between dichotomous outcome groups (i.e. abstinent/relapsed, treatment completers/dropout). c Mann Whitney U test. 
Predictor: d Logistic regression. e Linear regression. f Hierarchical linear regression. g Multi-level modelling. 
h Same sample at Lammers et al. (2015) 
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Chapter 3: Bridging Chapter 
The Systematic Review sought to establish whether five-factor model (FFM; Costa & 
McCrae, 1990) personality traits predict clinical outcomes of psychological interventions, 
and found several significant predictor relationships, broadly fitting the pattern of 
associations previously described by Bucher et al. (2019), with lower Neuroticism levels and 
higher Extraversion, Openness, Agreeableness and Conscientiousness levels associated 
with more favourable outcomes, though very few trends positive predictor relationships 
were identified. Conscientiousness was found to be a significant positive predictor for the 
widest range of outcomes, including abstinence (from gambling), coping skills, symptom 
severity, remission, and treatment completion, though no significant predictor relationship 
was seen in over two thirds of outcomes investigated. 
It was apparent that the current available literature for the predictive value of 
client personality traits with regard to outcomes of psychological interventions is very 
limited. However, research into associations between these factors across treatment types 
(e.g. Bucher et al., 2019) has shown specific patterns of outcomes, as described above, 
associated with more favourable outcomes. Specific traits have also been shown to have a 
mediator role in developing therapeutic alliance (Hirsh et al., 2012). Exploring the 
relationship between personality traits and treatment outcomes may be useful for other 
areas where findings are notoriously varied and poor, such as forensic settings, to help 
understand the complexities of the mechanisms of action and change in treatment. This 
would also allow clinicians to consider additional adaptations to increase patients’ 
engagement and responsivity to treatment. 
Forensic Mental Health Services in the United Kingdom (UK) 
Research into treatment outcomes in forensic settings is primarily undertaken in 
prisons, with heavily standardised group programmes targeting different rehabilitation 
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needs, both for mental wellbeing and offending behaviour (Buchanan & Grounds, 2011). 
Research into treatment outcomes of psychological interventions in U.K. inpatient forensic 
mental health services (FMHS) is scarce, suffering from small sample sizes and low 
response rates, as well as a lack of longer follow-up (over six months; MacInnes & Masino, 
2019). This is largely due to challenges of designing research studies in this setting, where 
patients’ individual needs vary greatly (as does the focus of their treatment and their 
outcomes, consequently), therefore there is a lack of standardisation of interventions 
across settings (e.g. Hockenhull et al., 2015) and a sparsity of available routinely collected 
clinical outcomes measures (Fitzpatrick et al., 2010) to cover a broad range of clinical 
outcomes for retrospective data collection. Outcomes of the research tend to focus on 
important behavioural outcomes such as recidivism and re-admissions, whilst few studies 
focus on clinical outcomes (Empirical Paper Introduction, p. 75). Findings for outcomes in 
FMHS are generally poor, with high levels of recidivism and re-admission (e.g. Coid et al., 
2007, Davies et al., 2007; see the Empirical Paper Introduction and Discussion sections for 
further discussion, not to be replicated here). Given the high financial cost of FMHS 
treatment to society (Empirical Paper Introduction, p. 75), as well as the ethical 
implications of detaining individuals against their will for treatment, it is important to seek 
to increase the efficacy of treatment in FMHS. As treatment in FMHS is multimodal 
(including the therapeutic milieu, medication, personal and physical security and 
individually targeted group and individual psychological and occupational interventions), it 
is difficult to separate and evaluate the efficacy of individual components. Therefore, to aid 
this pursuit, it is important to understand the factors involved in patients’ response to 
treatment and account for individual differences and their impact on individuals’ readiness 
for treatment, engagement and ability to benefit from treatment as it is delivered in 
practice.  
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As seen in the evidence described above, as well as the findings from the 
Systematic Review into psychological interventions, individuals’ personality traits appear to 
have at least some impact on people’s outcomes from psychological interventions in a 
range of different settings. This may be of particular relevance in FMHS since patients in 
this setting have been shown to have elevated levels of pathological personality traits 
(Spaans et al., 2017), including high levels of personality disorders (PDs) and personality 
pathology which is subthreshold for PD diagnosis. The presence of pathological personality 
traits may impact on the effectiveness of treatment by impacting responsivity, engagement 
and adherence with treatment. For instance, antagonistic traits may hinder engagement in 
treatment, whereby anti-authoritarian attitudes may negatively impact therapeutic 
relationships (Tetley et al., 2012), whilst a lack of Conscientiousness, and desire to improve 
relationships with others (i.e. callousness), may reduce attendance or commitment to 
treatment. Individuals with narcissistic traits (i.e. self-aggrandising presentations) have 
been shown to struggle with reflexivity, particularly regarding potentially shameful 
behaviours, and place blame on others (Pincus et al., 2014). This in turn leads them to 
disengage and terminate therapy more often than individuals who do not have elevated 
levels of these traits (Ellison et al., 2013). Research in forensic settings has shown that not 
completing treatment may lead to higher reoffending rates than not having any treatment 
(McMurran & Theodosi, 2007). Significant levels of hostility seen in individuals with both 
antagonistic and narcissistic traits can also evoke negative attitudes in therapists, which can 
also lead to a breakdown in therapeutic alliance (Tanzilli et al., 2015), which is key for 
positive outcomes in psychological interventions (Martin et al., 2000) and rehabilitation 
programmes (Ward et al., 2004). 
  Given the high levels seen in FMHS of these personality traits which may be 
problematic for therapeutic processes, a model of personality which looks at pathological 
traits would be well suited to capture the personality profile of patients. To allow 
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comparisons to be drawn with the established evidence base from research into 
personality traits, such a model should ideally correspond to established models which 
have been researched for many years, such as the FFM. One such model was recently 
developed whilst re-evaluating the diagnostic approach to PD whilst updating the 
Diagnostic and Statistical Manual of Mental Disorders, from the fourth edition revised 
(DSM-IV-TR; American Psychiatric Association [APA], 2000) to the fifth edition (DSM-5; APA, 
2013). This is the DSM-5 Alternative Model for Personality Disorders (APA, 2013; hitherto 
referred to as the DSM-5 model). 
To introduce the model by which pathological personality traits have been assessed 
within the Empirical Paper, the following narrative introduces the diagnostic approach to 
PD and the challenges it presents, and describes the development process of the DSM-5 
model. 
The DSM-5 Alternative Model for Personality Disorders 
PDs are a group of disorders (10 in the DSM-5) where an individual’s personality 
traits are maladaptive, inflexible and impact in a pervasive, negative and harmful manner 
on them and their interpersonal relationships (APA, 2013). PDs are understood to have a 
biopsychosocial origin, whereby people may have a genetic predisposition to the 
development of a PD, and experiences of difficult life events, including relationships, 
coupled with individual factors in youth such as: individuals’ temperament and personality 
traits, developed coping strategies, mental representations of themselves, others and the 
outside world (including attachment), and their narrative identities (Shiner, 2009). 
The approach and criteria for diagnosing and classifying PD has been criticised from 
many angles, including poor diagnostic efficiency (Grilo et al., 2001), arbitrary cut-offs 
(Widiger & Trull, 2007), high comorbidity rates (Oldham et al., 1992) and simultaneously 
heterogeneity between patients with the same diagnosis (Johansen et al., 2004). Indeed, 
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that is a difficulty shared across clinical disorders, and remains a core argument against its 
value in treatment versus the use of formulation (Bentall, 2004). It is far more likely for a 
person to meet a diagnosis of more than one disorder than to fit the criteria of one 
exclusively (Brown et al., 2001). Furthermore, the diagnostic system for PD does not cover 
personality psychopathology adequately, as evidenced by the “PD-not otherwise specified” 
(PD-NOS) diagnosis being widely overused (Verheul & Widiger, 2004). 
For this reason, when it came time to develop the DSM-5, a Personality and 
Personality Disorder Work Group (i.e. the Work Group) sought to move classification 
towards a dimensional trait based understanding of personality pathology, reflecting the 
established dimensional models of non-clinical personality (e.g. FFM). They developed a 
classification model in which a combination of the presence of pathological personality 
traits and ratings of functional impairment across self (identity, self-direction) and 
interpersonal (empathy, intimacy) domains would be needed to diagnose PD (Skodol et al., 
2011). They also proposed seven categorical diagnoses, based on the previous 10 in the 
DSM-IV-TR (APA, 2000), which were based on matching specific trait facets with original 
DSM-IV (APA, 1994) criteria. An extra diagnosis, “PD: trait specified”, was the only new one 
and did not have a set trait profile, rather allowing for an independent configuration that 
entails marked impairment.  
The Work Group developed this model through a three-step process (Krueger et al., 
2011) of literature reviews of the traits covered by PD diagnoses in the DSM-IV-TR (APA, 
2000) and the dimensional models widely used in literature (Widiger & Costa, 1994, 
Widiger & Simonsen, 2005). Experts in the field were then consulted on the clinical 
usefulness of these, and removed any that were redundant, and a questionnaire was 
produced to assess for the presence of these traits. After extensive psychometric analyses a 
220-item instrument, the Personality Inventory for DSM-5 (PID-5; Krueger et al., 2012), was 
finalised, with 25 primary trait facets and five higher order trait domains of personality 
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pathology (hitherto referred to as “traits”). The resulting DSM-5 hierarchical dimensional 
trait system resembles most closely maladaptive variants of the domains of the FFM (Costa 
& McCrae, 1990). Table 13 shows the personality trait correlates between the two models. 
The fifth DSM-5 model trait, Psychoticism, has repeatedly shown inconsistencies in the 
literature; both in the relationship between it and FFM’s Openness, and with corresponding 
domains in other models (Trull & Widiger, 2013). The correlations with this trait therefore 
remain not hypothesized but explored (Morey et al., 2015). Ultimately, the APA Board of 
Trustees placed the model in Section III of the DSM-5 (Emerging Measures and Models) for 
further study, until more empirical evidence for the model and diagnostic system is 
produced. Nevertheless, it was still deemed a working alternative to the established 
diagnostic model, and diagnoses from the DSM-5 model may be made by using the DSM-5 
code “Other Specified Personality Disorder” (301.89) and using the DSM-5 model for 
specification. Researchers have hailed the shift as “having the potential to transform 
psychopathology assessment in a manner that makes diagnosis increasingly evidence-
based and clinically useful” (Hopwood & Sellbom, 2013).  
 
Table 13. Correlates Between DSM-5 Personality Traits and the Five-Factor Model (Costa & 
McCrae, 1990) 
DSM-5 Personality Trait FFM Personality Trait 





Note. Italicized traits are reversed and correlate in a negative manner. 
Abbreviation: DSM-5, Diagnostic and Statistical Manual of Mental Disorders, 5th edition 
(American Psychiatric Association, 2013). 
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Since the present Empirical Paper was first designed, a new revision of the 
International Classification of Diseases (11th ed., [ICD-11]; World Health Organization, 2019) 
has been published. This classification system has also moved towards a dimensional trait- 
and severity of impairment-based diagnostic approach to PD, focusing on core personality 
dysfunction. The 10 PD categorical diagnoses from the DSM-IV-TR and ICD-10 (and 
maintained in the DSM-5) were removed and replaced by a general diagnosis of 
“Personality Disorder” with three severity levels: “Mild Personality Disorder”, “Moderate 
Personality Disorder”, and “Severe Personality Disorder”. The diagnosis can be specified by 
prominent assessed trait qualifiers: Negative Affectivity, Detachment, Dissociality, 
Disinhibition, and Anankastia. There are no polythetic criteria (where a minimum number 
of symptom criteria must be present to meet a disorder/non-disorder threshold, as in the 
ICD-10 and DSM-IV-TR) for the diagnosis in the ICD-11. Instead, diagnosis is based on a 
global evaluation of personality functioning. In addition, the ICD-11 allows for coding of a 
subthreshold “Personality Difficulty”, as well as a “Borderline Pattern” qualifier. The latter 
was put in as a response to the wider community of clinicians and researchers’ argument 
that several decades of research shows strong evidence for a separate clinical profile for 
Borderline PD, and it was felt that it would help by serving as a “familiar indicator for 
choosing psychotherapeutic treatment consistent with established theory and treatment 
manuals” (Bach & First, 2018, p. 5). This qualifier does require the presence of five of nine 
polythetic criteria.  
Aims of the Empirical Paper 
The Empirical Paper sought to contribute to the research into factors affecting 
patients’ clinical outcomes in FMHS, by investigating whether individual differences in 
personality traits may influence patients’ response to treatment.  
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Chapter 4: Empirical Research Paper 
The following paper has been prepared in accordance to the Journal of Forensic Psychology 
Research and Practice; author guidelines can be found in Appendix C. Tables have been 
included in position and British English spelling has been used for the purpose of the thesis 
portfolio. Additional documents included for the purpose of the portfolio only are included 
in the appendices and indicated in text. The manual for the Historical Clinical Risk 
Management-20, Version 3 (Douglas et al., 2013) and the Personality Inventory for the 
DSM-5 (Krueger et al., 2012) are not included for copyright reasons. 
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Introduction: Treatment in forensic mental health services (FMHS) is multimodal and the 
patient population is complex, with varied presentations. To understand more about the 
mechanism of change of treatment in FMHS, it is important to explore the role of patient 
characteristics. Research suggests that individuals’ personality traits have an impact on 
their outcomes from treatment in a range of settings including mental health. The present 
study sought to establish whether personality traits are significantly associated with clinical 
and risk outcomes in FMHS. 
Method: Twenty patients in FMHS (minimum 18 months admission) completed the 
Personality Inventory for DSM-5 (Krueger et al., 2012). Their personality traits were 
correlated with their change in treatment outcome scores from admission (Health of the 
Nation Outcome Scale – Secure [HoNOS-secure]; Sugarman & Walker, 2007; and the 
Historical Clinical Risk Management-20, Version 3, [HCR-20V3]; Douglas et al., 2013). 
Reliable change indices were used to determine the whether they had made reliable and 
clinically significant change. 
Results: Few individuals made reliable change on the HoNOS-secure Clinical (18.75%) and 
Security (12.5%) scales, as well as the HCR-20V3 Clinical (18.75%) and Risk (31.25%) scales 
respectively, with only one individual’s change showing clinically significant change, on the 
HCR-20V3 Clinical scale. No significant correlations were detected between personality traits 
and changes in HoNOS-secure and HCR-20V3 scales. 
Conclusion: It was not possible to determine the relationship between personality traits 
and clinical and risk outcomes due to little significant change being demonstrated. Further 
research is needed, both into the outcomes of treatment in FMHS and the association 
between personality traits and response to treatment. 
Keywords: Personality traits, DSM-5 personality traits, forensic, treatment outcomes, 
secure services, Personality Inventory for the DSM-5 (PID-5) 
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 Introduction 
In the United Kingdom (UK), treatment in inpatient forensic mental health services (FMHS) 
is provided for “(a) individuals with a mental disorder (including neurodevelopmental 
disorders) who (b) pose, or have posed, risks to others, and (c) where that risk is usually 
related to their mental disorder” (Joint Commissioning Panel for Mental Health, 2013, p. 3). 
There are currently approximately 630 beds in High Secure Units (HSU), 2800 beds in 
Medium Secure Units (MSU), and 2500 beds in Low Secure Units (LSU; Centre for Mental 
Health, 2019), with population rates of psychiatric detention at 74.8 per 100,000 (Hewlett 
& Horner, 2015).  
Treatment in FMHS, as defined by the Mental Health Act 1983 (amended by the 
Mental Health Act 2007, [MHA]), is multimodal; it includes “nursing, psychological 
intervention and specialist mental health habilitation, rehabilitation and care” and serves 
the purpose “to alleviate, or prevent a worsening of, the disorder or one or more of its 
symptoms or manifestations” (s. 145). From the perspective of the National Health Service 
(NHS), it equally serves the purpose of treating clinical needs and reducing risk (which are 
only in some cases linked), both for the individual and for the protection of others (NHS 
England; 2014, 2018a, 2018b). Evidence for effective treatments for people in FMHS is 
limited however (Knabb et al., 2011), and long-term outcomes, from the few available 
studies, are poor. Davies et al. (2007) followed up on patients from MSU after 20 years and 
found that 49% of patients had been reconvicted and 38% had been readmitted to FMHS. 
Additionally, they found that 57 patients (10.29%) had died during the follow-up period, 
one third from suicide. The average length of stay is 18–24 months but reaches five years 
for 10–20% patients (Rutherford & Duggan, 2007). This therefore causes an ethical issue, as 
detention for treatment is largely involuntary (Gunn & Taylor, 2014), and patients are not 
receiving timely, effective treatment. Furthermore, treatment in FMHS is not only 
restrictive, but also expensive for society, with annual equivalent costs per bed currently 
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ranging between £153,300–357,335 (for LSU and HSU respectively), and 20% of the U.K. 
mental health services budget going towards secure care (Centre for Mental Health, 2019). 
It is important therefore to target research to understand the mechanisms of change and 
factors involved in outcomes of treatment in FMHS. 
Personality Traits and Treatment Outcomes 
One form of individual difference that has been shown to have an impact on 
treatment outcomes in clinical settings are personality traits. In recent years, the 
understanding and description of pathological personality traits, such as those found within 
forensic populations (Spaans et al., 2017), has begun to shift away from a diagnostic model, 
towards models that include trait-based classification and formulation. In the Diagnostic 
and Statistical Manual of Mental Disorders, 5th edition (DSM-5; American Psychiatric 
Association [APA], 2013) Section III, a dimensional model of personality traits was 
developed as a novel way to conceptualise personality pathology and diagnose personality 
disorders (PDs) in clinical populations (i.e. DSM-5 model; see the Bridging Chapter for a 
discussion on the background and development of this, p. 69). This model includes five 
pathological personality trait domains: Negative Affect, Detachment, Antagonism, 
Disinhibition, and Psychoticism (hitherto DSM-5 personality traits). It was drawn from 
established dimensional models of personality traits, primarily the five-factor model (FFM; 
Costa & McCrae, 1990), which has been extensively researched across various population 
groups. The personality trait correlates between the two models can be seen in Table 13 
(Bridging Chapter, p. 71). 
A recent meta-analysis by Bucher et al. (2019), showed a pattern of associations 
between FFM traits and various outcomes of mental health treatments. Broadly, they 
found that a pattern of lower levels of Neuroticism and higher levels of Extraversion, 
Agreeableness, Conscientiousness, and Openness to Experience (i.e. lower Negative Affect, 
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Detachment, Antagonism and Disinhibition and higher Psychoticism, in the DSM-5 Model)  
were associated with more improvement in outcomes such as abstinence, treatment 
attendance and completion, working alliance, coping skills, symptom severity, and other 
client-rated experience such as satisfaction with therapy and confidence. Psychoticism has 
repeatedly shown inconsistencies in the literature, both in the relationship between it and 
FFM’s Openness, and other corresponding domains in other models (Trull & Widiger, 2013), 
so researchers conclude that for now the correlations with this trait remain not 
hypothesized but explored (Morey et al., 2015). Detachment has also shown a balance of 
conflicting results (Morey et al., 2015). 
Personality Traits in FMHS  
Pathological personality traits (e.g. antisocial and narcissistic personality domains) 
are common in the forensic population, regardless of whether PD is formally diagnosed. For 
instance, Spaans et al. (2017) undertook a meta-analysis of self-reported personality traits 
in forensic populations, finding significantly higher levels of antisocial and psychopathic 
features (which correlate to Antagonism in the DSM-5 model). Indeed, antisocial 
behaviours themselves can be conceptually linked to different personality dimensions. In a 
meta-analysis on the relationship between antisocial behaviours and dimensions of 
personality featuring 59 studies, Miller and Lynam (2001) found that the FFM dimensions 
of Agreeableness and Conscientiousness were negatively correlated with antisocial 
behaviours, whilst Neuroticism was positively correlated (within the DSM-5 model this 
would correlate to a positive correlation with Antagonism and Disinhibition, and a negative 
correlation with Negative Affect).  
A review by Hopwood and Sellbom (2013) on the implications of the DSM-5 model 
for forensic psychology concludes that future research should continue to expound upon 
the recent uptake of investigations into stable personality-relevant dynamics, one of “the 
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fundamental dimensions along which individuals tend to vary” (Hopwood & Sellbom, 2013, 
p. 320) and their effect on dynamic risk factors, which focus on clinical and risk 
management variables and are amenable to treatment (Douglas & Skeem, 2005). To the 
best of the researcher's knowledge, no studies have investigated the effects of dimensional 
personality traits on response to the multimodal treatment provided in FMHS. 
This study sought to bridge this gap, to understand whether personality traits are a 
form of individual differences that explain peoples' response to treatment in FMHS and 
what the nature of this relationship may be. The findings are relevant both for the 
improvement of treatment outcomes and reduction of risk, as well as to help inform the 
most effective and cost-effective use of resources. 
Hypotheses and Research Questions 
It is hypothesised that patients’ response to treatment in FMHS will be impacted by 
the presence of DSM-5 personality traits. As evidence of the relationship between these 
traits and response to treatment has been conflicting so far, the following hypotheses are 
made, following the balance of available evidence for each trait: 
Compared to participants who did not respond to treatment (i.e. show significant 
reliable and clinical change), those that did respond will have: 
1. Lower scores for Negative Affect and Antagonism. 
2. Higher scores for Disinhibition. 
As evidence for Psychoticism and Detachment remains scarce and divided, including the 
validity of the Psychoticism trait (e.g. Morey et al., 2015), an exploratory stance will be 
employed for the following research question:  
 Is there a significant relationship between Detachment and Psychoticism and 




Ethical approval for the study was sought and granted by the NRES Committee East 
Midlands – Leicester Central (Appendix D). 
Design and Inclusion Criteria 
This study employed a cross-sectional design. The predictor variable was DSM-5 
personality traits (five traits made up of 25 personality facets). The criterion variable was 
treatment response, as measured by the amount of change on two outcome measures 
following a period of treatment in hospital. For a detailed discussion of the planned 
method and reasons for changing this, see the Extended Methodology chapter (p. 109). 
To be included in the study patients had to have been resident in FMHS for a 
minimum of 18 months, consistent with findings of the average length of stay, to ensure 
adequate opportunity to benefit from treatment. Participants had to have at least two 
available data sets of the routine assessments of clinical need and risk (described below) 
completed in their clinical files. As some patients had transferred from other units during 
their period of admission, it was not possible to access their baseline measures. A 
secondary inclusion criterion of a minimum of six months between individuals’ pre- and 
post-treatment measurement points was adopted. Participants had to have an adequate 
understanding of conversational or written English in order to complete study procedures. 
Potential participants were excluded if they were experiencing significant mental health 
symptoms such that they are not able to participate in routine ward-based activities and/or 
lacked capacity to make an informed choice about participation. 
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Participants 
Participants were recruited from the two largest providers of FMHS in the East of 
England (Suffolk, Norfolk, Cambridgeshire); Norfolk and Suffolk NHS Foundation Trust 
(NSFT), and Kneesworth House Hospital, part of Priory Group (formerly Partnerships in 
Care), in Royston, UK. The FMHS at NSFT include MSU at Norvic Clinic in Norwich, and LSU 
at Hellesdon Hospital in Norwich and Foxhall House in Ipswich. Kneesworth House includes 
LSU, MSU and Locked Rehabilitation. It was not possible to establish how many patients 
met eligibility criteria across the services due to eligibility verification occurring after 
patients had signed expression of interest. 
Twenty patients agreed to take part in the study. A further 13 had signed up to 
express interest but did not participate (eight declined to participate, three did not meet 
eligibility criteria and one patient was discharged). Participant demographics can be found 
in Table 14. Participants’ ages ranged between 30–84. The most prominent diagnostic 
category was PD. Five participants (35.71%) had more than one PD diagnosis whilst two 
(14.28%) had a diagnosis of Mixed PD from the International Classification of Diseases, 10th 
Revision (ICD-10; World Health Organization,  2004), a diagnosis used when symptoms of 
several PD are present, but “do not demonstrate the specific pattern of symptoms” of the 
other PD diagnoses. A further two participants (14.29%) were diagnosed according to the 
new 11th Revision of the ICD (ICD-11; World Health Organization, 2019) dimensional 
classification of PD, with defined prevalent traits. Seventeen participants (85%) had an 
index offence, of which nine (52.94%) had more than one. Further to the index offence 
categories  in Table 14, there were a number of offences that no more than two people 
had; Absconding from lawful custody; Aggravated vehicle taking; Child abduction; Burglary; 
Kidnapping; Murder; Rape; Robbery; Sexual assault; Sexual assault on minor; Theft; and 
Threats, conspiracy or incitement to murder. The time between first and most recent 
assessments ranged between 272–2972 days (M = 1098.81, SD = 811.75) or 8.94–97.71 
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Table 14. Demographics of the Sample (N = 20) 
Gender n (%) 
 Male 16 (80) 
 Female 4 (20) 
Level of Security 
 Medium secure 12 (60) 
 Low secure 6 (30) 
 Locked rehabilitation 2 (10) 
Legal Status (U.K. Mental Health Act 1983)  
 Detained under Section 3a 3 (15) 
 Detained under Section 37b  6 (30) 
 Detained under Section 47, 48 or 49c 11 (55) 
Diagnosis Category 
 Comorbidity (more than one diagnosis) 10 (50) 
 Personality Disorder 14 (70) 
 Psychotic Disorder 9 (45) 
 Paraphilic Disorder 2 (10) 
 Substance Use or Dependency Disorder 2 (10) 
 Bipolar Disorders 1 (5) 
 Depressive Disorder 1 (5) 
 Learning Disability (Mild) 1 (5) 
 Trauma and Stressor-Related Disorder 1 (5) 
Index Offence Category (U.K. Criminal Law) (n = 17) 
 Malicious wounding and other like offences 8 (47.1) 
 Arson 3 (17.6) 
 Attempted murder 3 (17.6) 
 Other offences 17 
a This is a civil section of the U.K. Mental Health Act 1983 (amended by the Mental Health 
Act 2007) used to detain psychiatric patients outside of the criminal justice system.  b This is 
a criminal justice section used to detain psychiatric patients after being convicted for an 
offence. c This is used to transfer prisoners to a psychiatric hospital for treatment. 
 
months for HoNOS-secure, and 198–2194 days (M = 995.25, SD = 640.62), or 6.51–72.13 
months, for HCR-20V3. 
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Procedure 
Non-randomised convenience sampling was employed. A poster advertising the 
study was put up in each participating ward (Appendix E). The researcher (AS) attended 
each ward and the nursing team indicated patients (without sharing any personal details) 
who had been resident at the service for a minimum of 18 months (though other eligibility 
criteria was not yet ascertained, following ethical approval). The researcher approached 
these patients to ask whether they would be happy to hear about the research study. All 
those who were interested were told about the study, then invited to participate. They 
were also told that participants would receive a reward for participating, in the form of 
being entered into a prize draw to win one of fifteen £15 Amazon vouchers, and that the 
study and researcher were independent from their treatment, and their choice whether to 
participate would not affect their treatment. Patients signed up to express their interest 
and consent to contact (Appendix F), and the gatekeeping clinician (ward psychologist or 
Responsible Clinician) checked their eligibility according to inclusion criteria. Eligible 
patients met with the researcher to go through the Patient Information Sheet (Appendix G) 
and give informed consent (Appendix H) to participate, and then completed the 
questionnaire outlined below. Further information about the procedure and particular 
considerations for the population can be found in the Extended Methodology chapter (p. 
107 and p. 116 respectively).  
Measures 
Personality Inventory for the DSM-5 (PID-5; Krueger et al., 2012) 
The PID-5 is a 220-item self-report measure which was created by the DSM-5 
Personality and Personality Disorders Work Group to assess DSM-5 personality traits. It 
measures the presence of 25 personality trait facets which are then grouped into the five 
DSM-5 personality traits. Each item is rated on a 4-point scale, with several items 
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corresponding to a personality facet. Personality facets are grouped together by their 
corresponding personality domain and an average of their combined scores is calculated on 
a 4-point scale to create an average score for each domain. Reliability of DSM-5 personality 
traits as measured by the PID-5 are high (in Krueger et al., 2012, Cronbach’s α ranged .72–
.96, median = .86). 
Health of the Nation Outcome Scale – Secure (HoNOS-secure; Sugarman & Walker, 2007; 
Appendix I) 
The HoNOS-secure tracks treatment outcomes and on-going security needs of 
patients in FMHS, by rating clinical need for care and risk management. It is commissioned 
by NHS England for all FMHS (NHS England; 2014, 2018a, 2018b), first completed within 
three months after admission, then at subsequent Care Programme Approach meetings 
taking place at 6-month intervals. It is part of a group of outcome measures originating 
from the Health of the Nation Outcome Scales (HoNOS; Wing et al., 1998), which comprises 
12 clinician-rated items relating to behaviour, impairment, symptoms, and social 
functioning outcomes, originally designed for use with working-age adults. Other HoNOS 
tools have been amended for specialist populations. HoNOS-secure covers the original 12 
HoNOS items (i.e. Clinical scale), as well as an additional 7-item Security scale. Any item 
that is rated above “1” must receive a targeted approach in the patient’s care plan and a 
risk management strategy. It was standardised in the UK and has been shown to have 
moderate to substantial inter-rater consistency (in Dickens et al., 2007, Cronbach’s α = .73 
for Security and .79 for the Clinical scale) and be a reliable outcome measure when used in 
routine clinical practice (Kappa values > .53 for six out of seven items for Security scale, and 
> .65 for eight out of 12 items on the Clinical scale; Sugarman et al., 2009). In a review of 19 
routine outcome measures, Shinkfield and Ogloff (2014) found that HoNOS-secure is one of 
six suitable to be used in FMHS, due to covering a broad range of relevant outcomes in the 
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areas deemed necessary: Functioning, Recovery, Risk, and Placement Pathway (for further 
discussion see the Discussion chapter, p. 135). 
Historical Clinical Risk Management-20, Version 3 (HCR-20V3; Douglas et al., 2013) 
HCR-20V3 is a structured professional judgement tool (Department of Health, 2007), 
standardised in a North American population, for the assessment and management of the 
risk of violence. It allows the assessor to establish the presence and relevance of 20 known 
risk factors for violence from Historical, Clinical and Risk Management domains, and 
enables the development of targeted risk management strategies to support individuals 
(Douglas et al., 2014). It has high reliability shown in several smaller studies (in Douglas & 
Belfrage, 2014, intraclass correlation ranged .94–.98 for the Historical scale, .86–.95 for 
Clinical, .75–.90 for Risk, and .94–.98 for the Total score). Further studies have looked at 
the previous version of the HCR-20 (Version 2, Webster et al., 1997; e.g. O’Shea & Dickens, 
2015), and a high internal consistency has been shown between V2 and V3 (r = .84 for Total 
sum scores, .87 for Historical, .76 for Clinical and .82 for Risk, Douglas & Belfrage, 2014). 
The use of HCR-20V3 in adult FMHS in England is recommended by the U.K. government 
(Department of Health and Social Care, 2009) and is a commissioning requirement for HSU 
(NHS England, 2014). Though it is used clinically as an assessment of risk for forward-
planning, it has been used as a measure of clinical and risk outcomes in research (e.g. 
Longdon et al., 2018).  
Voluntary Status 
Participants were also asked to indicate on a 10-point Likert scale “Do you believe 
that you need treatment in hospital?” (1 = no/strongly disagree to 10 = yes/strongly agree) 
to consider whether they agree with their need for treatment, as volunteering to take part 
in treatment has been shown to have significant positive effects on clinical progress (Parhar 
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et al., 2008). The results and discussion of the analysis of this data can be found in the 
Additional Results and portfolio Discussion chapters (p. 125 and 127 respectively). 
Data Collected from Clinical Files 
A file review was undertaken to extract participant data, including: demographics, 
diagnosis, index offence, MHA section, engagement in formal psychological intervention, 
and whether they were established on a medication regime. Inconsistencies in reporting 
and recording data prevented meaningful secondary analysis of these factors. HoNOS-
secure and HCR-20V3 scores from the first available and two most recent assessments were 
obtained. The final analysis utilised only the first (T1) and most recent (T2) available scores. 
Analysis 
Data analysis was conducted using IBM SPSS Statistics v25. Kendall rank 
correlations (i.e. Kendall’s tau-b; τb) were considered between DSM-5 personality trait 
average scores and the change (between T1 and T2) on HoNOS-secure Clinical and Security 
scale scores and HCR-20V3 Clinical and Risk scale scores. The Holm–Bonferroni method 
(Holm, 1979) was used post hoc to adjust p values to control for familywise error rates. 
Reliable and clinically significant change criteria (Jacobson et al., 1984; Jacobson & Truax, 
1991) were applied to identify reliable changes in Clinical and Security needs on the 
HoNOS-secure, and the Clinical and Risk subcategories of the HCR-20V3.  
Reliable Change Index and Clinically Significant Change Calculations 
Reliable Change Indices (RCI) (Jacobson & Truax, 1991) were used to assess 
whether the amount of change on a measure is greater than would be expected given 
measurement error. The threshold for reliable change is calculated using the standard 
deviation and reliability of the measure (see the Extended Methodology section for the 
formula, p. 114). These are used to produce a range of change scores that includes 95% of 
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the change scores that would occur by chance. The individuals whose post-treatment 
scores are outside of this range are considered to have experienced reliable change on that 
specific measure. Jacobson et al.’s (1984) “Criterion a” methodology was used for defining 
Clinically Significant Change (CSC). This methodology states that the level of functioning 
after therapy should fall outside the range of the clinical population by more than 1.96 SD 
(towards a decrease in dysfunction) to be a clinically significant improvement. Table 15 
shows the alpha coefficients used when calculating the RCI for each outcome measure, and 
the normative data used for calculating CSC. Clinical norms were selected from studies that 
had the closest match to the present sample characteristics. For detailed information about 
RCI and CSC calculation method, as well as the process for choosing reliability data and 
clinical norms for calculation, see the Extended Methodology chapter (p. 114). 
Several participants were excluded pairwise from elements of the analysis. Four 
participants were excluded from analysis of treatment outcomes on HoNOS-secure due to 
missing assessment data (n = 16). Three participants were excluded from analysis of  
 
Table 15. Reliability Alpha Coefficients and Clinical Norms Used for HoNOS-secure and HCR-
20V3 Analysis. 
  Cronbach's α Clinical Norms 
M (SD) 
HoNOS-secure   
Clinical Scale .79a 11.90 (6.25)b 
Security Scale .73a 11.73 (4.23)b 
HCR-20V3   
Clinical Scale .94c 5.73 (2.36)d 
Risk Scale .93c 4.67 (1.83)d 
Abbreviations: HCR-20V3, Historical Clinical Risk Management-20, Version 3; HoNOS-secure, 
Health of the Nation Outcome Scale-secure. 
a Data from Dickens et al. (2007). b Data from Dickens et al. (2010). c Data from Douglas and 
Belfrage (2014). d Data from Neil et al. (2020).  
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HCR-20V3 treatment outcomes due to missing assessment data, and one due to too short 
assessment interval (< 6 months; n = 16). All 20 participants' data was retained for 
demographics and PID-5 descriptive statistics. 
 Results 
Response to Treatment 
RCI and CSC were calculated using the Leeds Reliable Change Indicator: Simple 
Excel(tm) (Morley & Dowzer, 2014). Table 16 shows the proportions of individuals who 
showed reliable and clinically significant change. It can be assumed with a confidence level 
of 95% that a reliable change has occurred if an individual’s change score is greater than 
the reliable change score for the measure (see Extended Methodology and Additional 
Results section for further information and plots of individuals’ scores, p. 114 and p. 121 
respectively). Most individuals did not show reliable or clinical change on either measure. 
There were three individuals who showed reliable improvement in scores on the Clinical 
scale of HoNOS-secure, and two on the Security scale, though neither of these changes 
were clinically significant. With regards to the HCR-20V3, three individuals showed reliable 
improvement on the Clinical scale, of which one individual’s improvement was also 
clinically significant, whilst five individuals showed reliable deterioration. On the Risk scale, 
five individuals showed reliable improvement, though none of these were clinically 
significant, and six showed reliable deterioration.  
A Kendall's tau-b correlation employing a two-tailed test of significance was run to 
determine the relationship between changes on HoNOS-secure and HCR-20V3 scales, as 
shown in Table 17. There were no significant correlations between any of the measures’ 
scales. A weak negative association was seen between the changes of HoNOS-secure 
Security and HCR-20V3 Risk scales, and a weak positive correlation was seen between 
HoNOS-secure Clinical and HCR-20V3 Clinical scales. Both correlations were not statistically
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HoNOS-secure          
Clinical  8.37 (6.19) 5.75 (3.86) 2.62 (5.77) .415 .49 0 (0) 13 (81.25) 3 (18.75) 0 (0) 
Security 15.75 (5.21) 12.44 (7.02) 3.31 (3.98) .829*** .49 0 (0) 14 (87.5) 2 (12.5) 0 (0) 
HCR-20V3          
Clinical  4.38 (2.78) 4.94 (2.82) -0.56 (2.56) .583* -.20 5 (31.25) 8 (50) 3 (18.75) 1 (6.25) 
Risk  6.69 (2.73) 6.50 (2.37) 0.19 (2.59) .491 .07 6 (37.5) 5 (31.25) 5 (31.25) 0 (0) 
Note. Change in scores between first and most recent available HoNOS-secure and HCR-20V3 assessments. Maximum possible scores: HoNOS-secure Clinical 
= 48, Security = 28; HCR-20V3 Clinical = 12, Risk = 12. 
Abbreviations: CSC, Clinically Significant Change; HCR-20V3, Historical Clinical Risk Management-20, Version 3; HoNOS-secure, Health of the Nation Outcome 
Scale-secure. 
*p < .05. **p < .01. ***p < .001. All two-tailed. 
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Table 17. Correlations Between Change in HoNOS-secure and HCR-20V3 Scale Scores (τb) (n = 
16) 
  1 2 3 
1. HoNOS-secure — Clinical  – 
  
2. HoNOS-secure — Security  .12 – 
 
3. HCR-20V3 — Clinical  .24 .17 – 
4. HCR-20V3 — Risk  -.12 -.22 -.07 
Note. Change in scores between first and most recent available HoNOS-secure and HCR-
20V3 assessments. 
Abbreviations: HCR-20V3, Historical Clinical Risk Management-20, Version 3; HoNOS-secure, 
Health of the Nation Outcome Scale-secure. 
*p < .05. **p < .01. ***p < .001. 
 
significant. The effect size for pre-post treatment on each scale (Cohen’s d) was calculated 
using a calculator of d from the test statistics of dependent t-tests (Lenhard & Lenhard, 
2016), employing Kendall’s tau-b data for the correlation between T1 and T2 means. 
Correlation Between Personality Traits and Response to Treatment 
A Kendall's tau-b correlation employing a two-tailed test of significance was run to 
determine the relationship between the DSM-5 personality traits and response to 
treatment, as shown in Table 18. No significant correlations were detected between 
personality traits and changes in HoNOS-secure and HCR-20V3 scales. With the small sample 
size (n = 16), the smallest significant correlation that could have been detected was .6, as 
calculated using G*Power 3 (Faul et al., 2007). Whilst non-significant, several weak 
associations were seen, as well as one moderate association. Antagonism had a weak 
positive correlation with change on the HoNOS-secure Clinical scale, and a moderate 
negative correlation with change on the HCR-20V3 Risk scale. Disinhibition showed weak  
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Table 18. Correlations Between DSM-5 Personality Traits and Change in HoNOS-secure and 
HCR-20V3 Scale Scores (τb) and Descriptive Statistics (n = 16) 
Note. Change in scores between first and most recent available HoNOS-secure and HCR-
20V3 assessments. 
Abbreviations: HCR-20V3, Historical Clinical Risk Management-20, Version 3; HoNOS-secure, 
Health of the Nation Outcome Scale-secure; PID-5, Personality Inventory for the DSM-5. 
*p < .05. **p < .01. ***p < .001. 
 
positive associations with change on the HoNOS-secure Security and the HCR-20V3 Risk 
scales. Detachment showed a weak negative association with change on the HoNOS-secure 
Security scale, and a weak positive association with change on the HCR-20V3 Risk scale. 
Psychoticism had a weak negative association with change on the HCR-20V3 Clinical scale. As 
stated, none of these associations were statistically significant. There were no associations 
with Negative Affect. 
 Discussion 
This study sought to establish whether there is a relationship between DSM-5 
personality traits and clinical outcomes of treatment in FMHS, as measured by change in 
 Negative 
Affect 
Antagonism Disinhibition Detachment Psychoticism 
HoNOS-secure 
Clinical .01 .26 -.15 .01 .05 
Security -.13 .14 .23 -.21 -.09 
HCR-20V3      
Clinical -.11 .08 -.15 -.11 -.24 
Risk .15 -.31 .24 .25 .05 
M 1.28 0.54 1.17 0.92 0.93 
SD 0.61 0.46 0.55 0.55 0.62 
Range 0.30–2.77 0.21–2.08 0.00–1.49 0.07–1.87 0.00–2.00 
 91 
scores on the HoNOS-secure and HCR-20V3 between admission and at least six months of 
treatment (87.5% of participants had received > 12 months of treatment). No significant 
relationship between any of the personality traits and change on the outcome measures 
were found. A secondary key finding of this study was that, with regards to treatment 
response, few people showed significant reliable change (ranging from 12.5% on the 
HoNOS-secure Security scale to 31.25% on the HCR-20V3 Risk scale), and only one person 
(5%) showed clinically significant change, seen on the HCR-20V3 Clinical scale. The lack of 
significant change will have impeded the possibility of establishing a relationship with 
personality traits. 
Several hypotheses can be made to explain the present findings. These must be 
considered in light of the evidence base and the reliability of the study’s findings, due to 
strengths and limitations of the methodological design. 
Treatment is Not Effective 
The first hypothesis is that treatment delivered in FMHS is not effective at treating 
the complex and varied difficulties presented by patients with complex mental health 
presentations, histories, and significant risks towards themselves and/or others, at least as 
measured by the HoNOS-secure and HCR-20V3. This could be explained either by the 
complexity of the clinical group or by deficiencies in the treatments themselves. As 
previously stated, treatment outcome studies for FMHS are scarce and vary greatly. The 
vast majority of studies looking at treatment outcomes in FMHS focus on outcomes of 
reconviction, imprisonment and readmission rather than clinical factors relating to patients’ 
mental health or wellbeing, which presumably are, to some degree, intermediate steps 
towards impacting the longer-term behavioural outcomes. Other studies looking at clinical 
outcomes have previously found change, though often not a large amount. For example, in 
a study also looking at clinical outcomes as measured by the HoNOS-secure and HCR-20 
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(Version 2), Longdon et al. (2018) found significant improvements on the HoNOS-secure 
Clinical Scale at six and 12 months of treatment, though fewer than half of participants had 
made clinically significant improvements, and no improvements were seen on the Security 
scale or HCR-20. It is reasonable therefore to expect to have seen some change in the 
clinical outcome measures. 
Sample Size 
The sample size was low in this study and therefore lacked power, which could 
affect the ability to detect significant effects. Indeed, correlations smaller than .6 could not 
be detected. However, analysis of treatment outcomes employed RCI and CSC methodology 
(Jacobson et al., 1984; Jacobson & Truax, 1991), which focuses on each individual’s change 
compared to the clinical norm population; therefore, the results for change on each of the 
measures’ scales are not impacted by sample size.  
Measure of Change 
It can be further hypothesised that the two measures used for treatment outcomes 
(HoNOS-secure and HCR-20V3) did not capture clinical improvement from effective 
treatment. Whilst HoNOS-secure and HCR-20V3 are arguably highly relevant measures for 
assessing meaningful change in the population being studied, there are potentially some 
limitations which could impact on their ability to reliably detect meaningful change in the 
current sample. 
Lack of Change in Scores May Not Indicate Lack of Improvement. It is possible that 
a lack of change in HoNOS-secure and HCR-20V3 scores, despite reliable completion of the 
measures, would not indicate a lack of clinical improvement. Longdon et al. (2018) 
hypothesised that lack of significant change in risk items (HoNOS-secure Security scale or 
the HCR-20) seen alongside an improvement in the HoNOS-secure Clinical scale could in 
fact be an indicator of progress in “identifying and quantifying risks” (p. 256). However, in 
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this present study this does not seem to be the case, as minimal change was seen on the 
HoNOS-secure Clinical as well as all scales, which precludes assumption of any clinical 
improvement. Dickens et al. (2010) had also found no significant change in HoNOS-secure 
Clinical scores between baseline and final rating (discharge or end of study period, 
whichever came first), but having tracked intermediate ratings, they identified an increase 
in Clinical scale scores in the first quartile of the treatment period followed by a significant 
improvement. A limitation of the present study procedure is that intermediate ratings were 
not collected, therefore it is not possible to ascertain whether this pattern may have 
occurred. Additionally, looking at subscale totals rather than item-level scores (as was done 
in the present study) may miss changes in presentation, such as when certain items could 
improve whilst others deteriorate. For example, a portion of individuals undergoing 
psychological therapy for Post-Traumatic Stress Disorder have been shown to experience a 
worsening of symptoms at the start of therapy (Foa et al., 2002; Tarrier et al., 1999), and a 
short-term increase in marital conflict and distress is reportedly experienced by some 
individuals in marital therapy (Hunsley & Lee, 1995).  
Discrepancy in Measure Completion. The measures were filled in as part of routine 
clinical practice rather than purposefully for research. It is possible that the approach to 
completing these varies between services and indeed individual raters. Both measures can 
be completed by individual clinicians or in collaboration with multidisciplinary team (MDT) 
colleagues; and based solely on file reviews or also refer to patient interviews and MDT 
discussion. This inconsistency may mean that the chosen measures were not valid, 
comparable measures of treatment outcome. However, the HoNOS-secure and HCR-20V3 
are the only measures consistently completed across all services in the UK for all patients 
(HCR-20V3 completed only if the patient presents a risk of violence). 
Are the Measures Capturing Clinical Improvement?. It could be further 
hypothesised that these measures do not capture a complete picture of what would be 
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defined as clinical and risk changes in response to treatment. As stated, the purpose of 
treatment in FMHS is to treat clinical needs and reduce individuals’ risk both towards 
themselves and others (NHS England; 2014, 2018a, 2018b). The difficulties experienced by 
patients in FMHS are complex. Individuals have often experienced significant adverse 
events, including marginalisation in society and poverty. These experiences will have 
contributed to developing maladaptive coping mechanisms (e.g. substance use, anger, self-
harm) and ways of meeting their perceived needs (e.g. crime; Ward, 2010), and their 
responses to their distress become expressed as the symptoms which fit diagnoses of 
mental disorders (Johnstone & Boyle, 2018). Their needs therefore are complex and wide-
ranging and are often linked in intricate ways, therefore capturing (and rating) change 
which can be constituted as improvement is a challenging endeavour. Furthermore, as 
treatment is multimodal and patients may receive different components due to differing 
needs, it can be difficult to contrast and compare outcomes. 
Nevertheless, HoNOS-secure has been shown to capture a good breadth of relevant 
factors for patients in FMHS compared to other measures (Shinkfield & Ogloff, 2014), and 
the HCR-20 (all versions combined) is the most widely used violence risk assessment in the 
world (Singh, 2013). Both the HoNOS-secure and HCR-20V3 capture an overview of patients’ 
clinical presentation during the assessment period whilst looking at a range of clinical 
factors, to rate how much difficulty individuals are experiencing in each and therefore 
require support and management (for the risk of violence in the case of HCR-20V3), and it is 
reasonable to expect these factors to change during treatment in FMHS.  
Patient-Specific and External Factors Affecting Treatment Uptake and Outcomes 
Many factors could impact on individuals’ experiences and needs at different times, 
as well as their ability to engage in, and benefit from, different treatments, which may not 
be due to the effectiveness of the treatment. For example, the environment in FMHS can 
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sometimes be challenging, and factors such as a ward social environment and atmosphere 
may impact individuals’ clinical presentation and wellbeing at different times (e.g. Hamrin 
et al., 2009, Long et al., 2011). They can also affect patients’ engagement (Casey et al., 
2007) and responsivity to treatment (Howells & Day, 2003), which in turn affect treatment 
outcomes. Therapeutic alliance with staff has been shown to moderate the likelihood of 
inpatient violence and disturbed behaviour (Long et al., 2011) and be a key feature of 
effective rehabilitation programmes (Ward et al., 2004). 
Richter et al. (2018) found that patients’ cognitive abilities had a significant causal 
relationship with their treatment outcomes in FMHS, whereby cognitive impairment 
mediated their ability to make progress in psychosocial treatment and therefore change in 
violence risk. Additionally, patients’ desire and motivation to engage with treatment can 
have a significant impact on treatment outcomes (Parhar et al., 2008). Due to the small 
sample size it was not possible to analyse the relationship between participants’ agreement  
with their need for treatment (as measured by their responses to the question “Do you 
believe that you need treatment in hospital?”) and their outcomes, nor any relationship 
with personality traits (see Additional Results and Extended Discussion chapters, p. 125 and 
127). It was also not possible to determine potential effects of sample bias or demand 
characteristics. 
In summary, despite constraints in the available data for measuring clinical 
outcomes of treatment, the measures used would be expected to be able to capture 
change following treatment in FMHS. However, the limitation of the narrow picture 
captured by the collected data means that it is not possible to exclude the possibility that a 
lack change in scores may not actually indicate a lack of improvement. Therefore, it is not 
possible to reliably conclude that participants did not show clinical improvement. 
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Measurement of Personality Traits 
It must also be noted that the self-reported measurement of pathological 
personality traits may not have been an accurate or complete representation of 
participants’ personality profile. It has been estimated that as many as 30% of civil forensic 
patients (Mittenberg et al., 2002), and nearly 20% of criminal forensic patients (Rogers et 
al., 1998), may over-report psychiatric symptoms. This is often intentional, for perceived 
gain such as less restrictive interventions, or due to a demand bias. In attempt to ensure 
that participants would not intentionally alter their responses, participants were explicitly 
told that the researcher is entirely separate from their treatment team, that their results 
would have no impact on their treatment and would be reported anonymously in the 
manuscript. However, it is not possible to ascertain that they trusted this and therefore had 
not altered their responses. Clinical presentation may also impact on responding, such as 
the more severe/prominent reporting of negative or “undesirable” personality traits by 
patients experiencing a major depressive episode (Bagby et al., 2008) or diagnosed with 
borderline PD (McGee Ng et al., 2016). The sample size did not allow for exploration of 
diagnostic differences in reported personality traits and how this related to expected 
profiles seen in certain diagnoses. As PID-5 is a relatively new measure and put forward by 
DSM-5 for research purposes rather than new clinical guidance, little published research 
with normative data exists, precluding the ability to compare our sample’s findings. 
Null Hypotheses 
Finally, the null hypotheses must be considered, that there is no relationship 
between DSM-5 personality traits and clinical outcomes of treatment in FMHS, at least in 
terms of the outcomes that were the focus of the study. Previous studies looking at the 
relationship between personality traits and treatment outcomes in a variety of healthcare 
populations, as well as psychological interventions, have found mixed and contradicting 
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results, including at times no relationship (e.g. in substance abuse, Muller et al., 2008; and 
PTSD, van Emmerik et al., 2011). Furthermore, the temporal stability of personality traits is 
subject to debate, and as the present study measured personality traits at post-treatment, 
we cannot rule out that personality traits may have been subject to change following 
treatment. (For a discussion of the debate about the stability of traits and implications of 
this for the field of research into treatment effectiveness and possible predictors of 
outcomes, see the Discussion chapter, p. 131). However, the lack of apparent significant 
change in treatment outcomes, which had been an intermediary assumption for the 
research question, meant that it would not have been possible to establish a relationship 
between personality traits and treatment outcomes. 
Clinical Implications and Future Research 
The present findings of a lack of response to treatment echo the known issues of 
poor outcomes within research into FMHS. There is a dearth of standardization in use of 
established psychometrics across FMHS, as well as minimal requirements for collection of 
data regarding a broad range of clinical outcomes. This causes further impediment to the 
possibility of expanding the evidence-base. The possible implications of treatment not 
being effective for people in FMHS are significant, given the ethical and financial 
implications of detaining people (most often) against their will, for the purpose of 
treatment. Equally, if these findings are due to limitations of the measures used to capture 
treatment outcome, this may suggest that, as the only measures commissioned to be used 
across all services (and available concurrently for all patients in the two present 
recruitment sites), when they are used alone to track clinical outcomes nationally, the data 
is limited and misleading. If they are the only standardly completed outcome measures to 
contribute clinical data to decision-making, the process and outcomes of the clinical 
decision-making process may need to be examined and guidelines revisited. However, it 
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cannot be discounted that the findings of this study lacked significant power due to a small 
sample size and provide a limited overview of change in response to treatment, which 
therefore precludes reliable interpretation.  
Therefore, the needs that drove the present study—to understand whether there is 
a link between personality traits as an idiosyncratic client-specific factor, and response to 
treatment—remain. Furthermore, it is clear both through the findings of this study, 
whereby little reliable or clinically significant change was seen in response to treatment, as 
well as the sparsity of evidence available, that further research into the outcomes of 
treatment in FMHS is warranted. Researchers should aim to recruit a large sample and 
capture as broad a range of outcomes, and over as long a time period, as possible. Areas of 
clinical outcome to cover should include the need for clinical intervention and risk 
management, and specific established measures of symptomatology relevant to each 
patient (e.g. a measure of psychotic symptoms for patients who have diagnoses of 
Psychotic Disorders and are receiving interventions for this). Researchers could supplement 
outcome measures with clinician and patient opinions regarding subjective improvement 
(e.g. My Shared Pathway, part of the Department of Health Quality, Innovation, 
Productivity and Prevention Programme for Secure Services), both to qualify changes and 
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Chapter 5: Extended Methodology 
This chapter offers additional information to the Methods section of the Empirical Paper. It 
presents details of the procedure undertaken with participants, as well as the planned 
design and analysis for the study, and a discussion about why it was not possible to employ 
this due to recruitment difficulties. Considerations for choosing an alternative design and 
analysis are presented, along with further information about the Reliable Change Index 
methodology and the choice of studies for clinical population data for comparison of means. 
Finally, ethical considerations for the research population are presented. 
Procedure 
Prior to recruitment 
The researcher (first author, AS) attended staff multidisciplinary meetings at each 
recruitment site to promote the study and outline inclusion criteria. Clinicians were asked 
to review the criteria and confirm (without sharing any personal details) that there would 
be an adequate sample available. A date was agreed for the researcher to attend each ward 
to undertake recruitment. 
Recruitment 
After attending the services to promote the study (see Procedure section in 
Empirical Paper, p. 82), the researcher met with gatekeeping clinicians to review the list of 
patients that had signed to express their interest in participating, and confirm that they met 
inclusion criteria. Participants’ literacy and comprehension levels were discussed to 
consider whether any adaptations would be necessary to facilitate their participation (i.e. 
how the questionnaire would be administered). If participants had identified difficulties, it 
was agreed that the researcher would automatically administer their questionnaire 
individually and read out the questions to them to ascertain that they understood the 
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questions and assist their understanding if needed. The gatekeeping clinician spoke to 
patients that did not meet inclusion criteria to explain this to them. 
Initial Meeting to Gain Informed Consent 
The researcher met with potential participants for an initial meeting to discuss their 
participation (see Empirical Paper Methods section, p. 82, and Ethical Considerations 
regarding Confidentiality below) and gain informed consent. If there were several 
consenting participants on the same ward, each participant was asked during their initial 
meeting whether they would be happy to complete the questionnaire in a room with other 
participants. This was done to maximise researcher time to facilitate maximum recruitment 
potential. The initial meeting was then concluded, and a time was agreed for the researcher 
to return to administer the PID-5 questionnaire (individually or in groups). The researcher 
spoke with the nursing team to ascertain whether it would be appropriate for the 
individuals to be in a room together and whether there were any known relational 
difficulties or risk factors which should preclude this.  
Questionnaire Administration 
Where participants had agreed to complete the questionnaire together with other 
people, the researcher administered the questionnaire to a maximum of five participants in 
a room on the ward. Participants were asked to sit at different locations in the room to 
ensure confidentiality of their responses on the questionnaire. The researcher explained 
the format of the questionnaire before beginning and answered any general questions that 
participants had about filling out the questionnaire. If participants had item-specific 
questions the researcher directed them to answer questions according to their 
interpretation, so as not to unduly influence their responses. Participants were asked their 
preference regarding how to complete the questionnaire; to have questions read aloud by 
the researcher with participants circling their answers on their pieces of paper, or for each 
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participant to read and complete their questionnaire independently. The majority of groups 
preferred to read it independently. The PID-5 took approximately 40 minutes to complete.  
Where participants had chosen to complete the questionnaire on their own, they 
met individually with the researcher and were offered the options of; reading and 
completing the questionnaire on their own; having the researcher read the questions out 
loud whilst participants circled their answers themselves; or for the researcher to read the 
questions out loud and also circle the answers that the participant would give verbally. 
Once the questionnaire was administered, the researcher met with each participant 
individually to debrief. Participants were directed to their Participant Information Sheet 
(Appendix G) where there was information about how to withdraw from the study if they 
wished to, including a telephone number for the researcher (see Contacting the Researcher 
below for information about this), and contact details for research supervisors and the 
service’s Patient Advice and Liaison Service, should any concerns arise. 
Data Collection 
The researcher attended the services on a separate day, after the PID-5 had been 
completed, to undertake file reviews for relevant data (as outlined in the Empirical Paper 
Methods section). 
Planned Study Design and Data Analysis 
The study was originally planned to have a cross sectional between-subjects design 
with two groups. The independent variable (IV) was to be treatment response with two 
groups, responders and non-responders to treatment, and the dependent variable was to 
be each DSM-5 personality trait domain (five domains made up of 25 personality facets).  
Assessment ratings for the HoNOS-secure and HCR-20V3 were collected for three 
time-points: admission (or first available assessment if transferred from a different service; 
T1) and most recent two assessments (T2 and T3). The following criteria was planned to 
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separate participants into the two IV groups (applied to each individual), subject to the final 
spread of data allowing for a balanced sample. Responders would have shown a change of 
over 1 SD (as a proportion of the total possible score) in HoNOS-secure and HCR-20V3 scores 
between T1 and T2, and this would have to have been sustained between T2 and T3. This 
change would denote a large effect size, indicative of clinically significant change (Wise, 
2004). If it had not been sustained, they would be classed as non-responders. An 
independent second person would follow the criteria to separate participants into the two 
groups and inter-rater reliability would have been calculated with Cohen’s κ. 
The difference between the responders’ and non-responders’ average scores on 
each of the five DSM-5 personality domains of the PID-5 would be analysed using two-tailed 
between-participants t-tests and a significance level of α = .05. If parametric assumptions 
were not met, Mann-Whitney U tests would be used at a significance level of α = .05.  
Secondary analysis was planned to explore the moderating effects of voluntary 
status, age, gender, diagnosis, index offence, legal status (Mental Health Act 1983, 
amended by the Mental Health Act 2007, [MHA]), engagement in formal psychological 
therapy, concordance with a medication regime, and number of incidents during the 
assessment period prior to T2 and T3. These secondary analyses were planned to be done 
using chi-square, t-tests, and analysis of variance, with post-hoc adjustments made for 
multiple testing. 
Recruitment Difficulties 
A target sample size of 68 (34 per IV group) was sought to detect medium-large 
effects (d = .7) with 80% power using a two-tailed t-test between means, with a significance 
level of α = .05, as calculated using the G*Power 3 computer program (Faul et al., 2007). 
During initial discussions, clinicians from the participating sites indicated that this number 
of patients meeting the inclusion criteria would be readily available. Despite previous 
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questionnaire-based research in FMHS indicating that a 60-70% response rate is realistic 
(Beazley & Gudjonsson, 2010), a much smaller proportion ultimately participated. It is not 
possible to calculate the final response rate due to the study procedure not capturing the 
total eligible patients, as eligibility was not ascertained until participants had signed their 
expression of interest and consent to share details and be contacted by the researcher. 
There are several contributing factors for the difficulties in recruitment. 
Presentation of the Study to Patients and Consent to Contact 
Ethical considerations regarding gaining consent to contact potential participants 
about the study, prevented the researcher from establishing patients’ eligibility ahead of 
speaking with them. Instead, the researcher spoke with clinicians from each service to 
ascertain the best opportunity to approach all patients at each ward as a group. It was 
indicated that this should be in regular patient meetings held every morning. However, it 
was found that very few patients attended the patient meeting on the first ward visited; 
therefore the researcher did not have an opportunity to speak to most of the patients 
about the study. Subsequently, few patients signed up to express interest and give consent 
to be contacted by the researcher. As there were 11 wards and the recruitment sites 
required considerable travel it was only feasible to attend once per ward. Wishing to avoid 
missed opportunities to recruit potential participants due to the low number of patients 
attending the ward meeting, it was agreed with gatekeeping clinicians that the researcher 
would attend each ward, and the nursing team would indicate patients who had been 
resident at the service for a minimum of 18 months. In keeping with ethical approval, 
personal details were not recorded and other eligibility criteria was not ascertained at this 
stage, prior to receiving signed consent to contact (as described above). Ward staff were 
asked to present the study information and expression of interest form to any patients who 
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were potentially eligible but were away on leave at the time of the researcher’s visit (which 
was the case for a number of patients). 
Challenges posed by ethical considerations of data protection as well as time 
constraints on the researcher’s ability to attend in person to attempt to recruit more 
participants, meant that few participants were recruited during the available recruitment 
period. In addition, several participants (n = 8, 27.59% of eligible potential participants who 
signed the expression of interest form) who had expressed interest and whose eligibility 
was confirmed, had decided not to participate when they met with the researcher to go 
through the Participant Information Sheet (Appendix G). 
Confirmation of Eligibility 
Further to a small number of participants being recruited during the recruitment 
phase, several participants also had to be excluded from analysis due to not having the 
required assessment data or not having been admitted in services for long enough, despite 
their gatekeeping clinicians having confirmed their eligibility. Indeed, as described in the 
Empirical Paper Methods section (p. 79), a number of participants were found to not have 
available baseline measures (as they had transferred from other units) after they had 
participated in the study, therefore a secondary criteria of a minimum of six months 
between T1 and T2 measures was adopted to minimise exclusion of participants’ data. 
Although clinicians from each ward at the two recruitment sites were asked to 
indicate in advance of recruitment approximately how many patients would meet length of 
stay eligibility criteria, to estimate that enough participants would be available, the 
information supplied was found to be overestimated. As previously described in the study 
procedure (see Empirical Paper Methods section, p. 82), the researcher undertook file 
reviews after the PID-5 questionnaire had been completed, with the assumption that the 
participants would have the required information as their gatekeeping clinician had 
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confirmed their eligibility. However, in several cases participants were found not to have 
the required data which excluded their data from analysis (see Participants subsection of 
the Empirical Paper Methods section, p. 80, for detailed reasons for exclusion). 
It is possible that changing the order of participation, whereby the file review for 
data extraction would occur straight after gaining consent, prior to PID-5 completion, would 
have allowed the researcher to ascertain that participants were eligible before 
administering the PID-5. However, this option would not have met ethical considerations; 
the researcher would have full access to medical records for patients who could turn out to 
not be eligible to participate in the study. Additionally, participants who were found eligible 
after their data was extracted from their medical file could also change their mind about 
participation when they met the researcher again to complete the PID-5; leading to the 
same ethical problem as well as a significant loss of time for the researcher. Therefore, the 
only ethical and feasible option for the process of determining participant eligibility was for 
clinicians to do this, placing the onus of accurate verification on them. The location of 
required data to confirm eligibility (length of stay minimum 18 months and availability of 
minimum two HoNOS-secure and HCR-20V3 assessments) on the electronic patient record 
systems (EPR) used by the services was not consolidated and will have made checking this 
an arduous task for clinicians. There were staff team changes during the recruitment period, 
which cumulated in difficulties and delays in communication, which further precluded the 
possibility of further recruitment efforts in the available recruitment time-period. 
Methods Adjustment 
Due to a small sample size and the lack of significant change in assessment scores, 
it was not possible to split participants into groups of responders and non-responders. It 
was decided that a correlation analysis would be the only way to explore the relationship 
between the DSM-5 dimensional personality traits and response to treatment. The choice 
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of test was determined by checking for satisfaction of statistical assumptions (as discussed 
in the Additional Results chapter, p. 120). As the recruited sample size was small, it was 
decided that the most robust method for calculating change in response to treatment 
would be using Reliable Change Index (RCI) and Clinically Significant Change (CSC). 
Reliable Change Index and Clinically Significant Change Calculation 
As described in the Methods and Results sections of the Empirical Paper (pp. 85-87), 
Jacobson and Truax’s (1991) methodology for calculating RCI and CSC (Jacobson et al., 
1984) determines whether individuals have shown a change (difference between scores) on 
measures following treatment that is significant at the 95% level, indicating that it is not 
due to a measurement error. 
An RCI is calculated for each individual, which indicates that the change in scores is 
significant at the 95% level when the RCI is higher than 1.96. The formula to compute the 




  ,      (1) 
where X1 represents the individual’s pre-treatment score, X2 represents their post-
treatment score, and Sdiff, is the standard error of difference between the two assessment 
scores, which can be calculated using the standard error of measurement (SEM) as seen in 
Equation 2: 
𝑆𝑑𝑖𝑓𝑓 = √2(𝑆𝐸𝑀)
2  .     (2) 
The SEM is estimated by using reliability data for the measure (either test-retest or 
Cronbach’s α), as seen in Equation 3: 
𝑆𝐸𝑀 =  𝑆𝐷1√1 − 𝑟𝑥𝑥 ,     (3) 
where SD1 represents the SD of the test group and rxx represents the reliability of the 
measure. A Reliable Change Score (RCS) is calculated for the scale, as shown in Equation 4, 
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which gives the actual change in scores needed to reach significantly meaningful change 
(95%) on the scale. 
𝑆𝑑𝑖𝑓𝑓 × 1.96       (4) 
Jacobson et al.’s (1984) “Criterion a” was used to determine whether individuals’ 
change in scores was clinically significant as well as being reliable. This methodology is used 
when data is not available for a normative (non-clinical) sample, as is the case for both 
HoNOS-secure and HCR-20V3, which are inherently used only for a specialist forensic 
population (HoNOS-secure) or where a significant risk of violence is expected (HCR-20V3). 
Instead data for a clinical sample is used to determine whether individuals have moved out 
of a clinical range. Equation 5 shows the formula for calculating this: 
𝑎 =  𝑀1 + 2𝑆𝐷1     (5) 
where M1 represents the Mean of the clinical population group pre-treatment. 
Choosing Reliability Data and Clinical Norms for Calculation 
As described in the Methods section of the Empirical Paper (p. 85), Jacobson et al.’s 
(1984) “Criterion a” methodology requires data from clinical populations to determine 
whether individuals have made CSC. For a clinically significant improvement, individuals’ 
post-treatment scores should fall outside the range of the clinical population, (i.e. 1.96 SD 
beyond the mean, towards a decrease in dysfunction). Clinical population norms were 
therefore needed for the HoNOS-secure and HCR-20V3. To increase reliability, studies were 
chosen to match the characteristics of the present sample. The following studies were 
chosen for reliability data for the measures (Cronbach’s α) and clinical population norms (M 
and SD). 
HCR-20V3. Few studies have looked at the reliability of the HCR-20V3. The most 
recent available study of the HCR-20V3’s reliability (Howe et al., 2016) was considered, 
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however due to the study’s methodological limitations described by the researchers, 
namely the lack of standardization of the timing of HCR-20V3 rating by researchers of the 
same individual (e.g. where some were completed at the beginning of an admission and 
some post-discharge), it was decided that their findings were unreliable. The study 
ultimately chosen (Douglas & Belfrage, 2014) was one conducted by the measure authors, 
conducted on a small sample during final stages of HCR-20V3 development. It was the study 
with the closest sample characteristics of the present study’s sample; with similar legal 
status (though according to Swedish legislation); age; and gender distribution. Clinical 
population normative data was obtained from Neil et al. (2020). This recent study was 
chosen instead of the study used for reliability data as it used a relatively large sample 
whose characteristics were similar to the present sample; similar setting of U.K. FMHS, legal 
status, and age. 
HoNOS-secure. Reliability data (Cronbach’s α) for the HoNOS-secure was obtained 
from Dickens et al. (2007). It was one of the few studies to have measured and reported the 
internal reliability of the measure and used a sample with similar characteristics, as above. 
Clinical population norms were obtained from Dickens et al (2010). This study’s sample was 
large, and the sample characteristics were the closest found to the present study. The study 
used for the measure’s reliability was not used due to patients having been discharged from 
MSU to community, thereby not matching the clinical characteristics of our sample. 
Ethical Considerations for the Research Population 
Several ethical considerations were made in planning this study, given the 
vulnerable nature of this population, detained under the MHA. 
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Consent and Self-Report 
Previous research has shown that using self-report methods in forensic populations 
that show deviant or disruptive behaviours is not always reliable; in many cases patients 
may be granted progressive leave and benefits, or, conversely, have their sentence 
extended or receive enforced treatment, according to the results of their assessments, 
treatment adherence and stability (Milton et al., 2005; Spaans, et al., 2015). It was 
important to make explicit that the research was independent of the services and that the 
decision to participate or not would have no bearing on patients’ treatment, to ensure that 
individuals would not be coerced to participate, and that their responses would remain as 
truthful as possible. Capacity was assessed according to standard trust policy. Clinicians 
were informed to notify the researcher if they felt that any potential participants, who were 
excluded from participation due to not having capacity during the researcher’s visit, had 
regained capacity and still wanted to participate in the study. Those patients could then 
undergo the same inclusion process as other participants. 
Confidentiality 
Participants were made aware both in the information and consent forms and 
during the interview with the researcher, prior to providing consent to being involved in the 
study, that their information would be kept confidential; although this would need to be 
broken if it was felt that they or others were at risk of harm or if a crime was reported. 
Participants were informed that if this occurred, a professional at the service would have to 
be informed. In this instance any relevant information was handed over immediately 
following the interview and where possible, they were also informed if this procedure 
needed to be put in place (providing that it did not place the participant or anyone else 
under increased risk), and this was documented. Participants were offered the option in 
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advance to have their ratings from the PID-5 shared with their lead clinician, to provide 
more information to benefit their treatment. 
Reward 
Participants were entered into a prize-draw to win one of fifteen £15 Amazon 
vouchers. This was discussed with local clinicians and they had expressed that it is standard 
local practice for research done in their services. Following Health Research Authority 
guidelines for Payments and Incentives in Research, it was agreed that this would form 
recompense “proportionate to the level of burdens involved” (Health Research Authority, 
2014), and would not form coercion. 
Potential Risks to the Researcher 
To ensure the personal safety of the researcher whilst conducting participant 
interviews in inpatient settings, all local safety protocols were followed onsite, including 
attending site inductions, and having an additional member of staff present where needed. 
Handover information was sought from the nurse in charge prior to the session to ascertain 
that the potential participants were not in a period of distress or heightened risk. After the 
interview, the researcher did a handover to the nurse in charge that the participant had 
been seen, and whether there were any clinical concerns raised by their presentation. 
Contacting the Researcher 
Participants were provided with a mobile telephone number for the researcher 
which they could use if they needed to discuss their involvement in the study, or wanted to 
withdraw from the study (during the period stated on the Participant Information Sheet). If 
a participant used this number to report to the researcher about any distress they were 
experiencing, then this would have been reported to a professional at the service 
immediately and documented. It was explained to participants that the researcher would 
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only be contactable during office hours (Monday-Friday, 9am-5pm) and that any issues 
unrelated to the study should be directed towards their care team. An answerphone 
message was left on the phone so that this message could be reinforced, and the mobile 
phone was switched off outside of working hours to maintain researcher-participant 
boundaries. No contact was made via this method.  
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Chapter 6: Additional Results 
This chapter provides additional results for the Empirical Paper. It outlines the statistical 
assumptions that were checked for the correlation analyses, and the considerations made 
where these were violated. It presents results of an exploratory analysis for associations 
between the DSM-5 personality traits, and the descriptive statistics for Voluntary Status 
and relationships between diagnostic groups and DSM-5 personality traits.  
Statistical Assumptions 
As discussed in the Extended Methodology chapter (Methods Adjustment section, p. 
113), correlation analysis was chosen to explore the association between response to 
treatment and DSM-5 personality traits. The following statistical assumptions for the 
Pearson product-moment correlation (i.e. Pearson’s correlation) must be satisfied: (a) 
having two continuous variables, (b) that are paired, (c) have a linear relationship, (d) have 
no significant outliers, and (e) the data must be normally distributed. The first two 
assumptions are determined by the study design and procedure; in the present study both 
assumptions were met. Determining the linearity of the relationship between the variables, 
as well as the presence of significant outliers was done by visual inspection of scatterplots. 
Finally, a Shapiro-Wilk’s test was used to determine whether the data for each variable was 
normally distributed. This showed that the data for Antagonism was not normally 
distributed (p = .042), whilst the remaining variables were normally distributed (p > .05). 
Upon visual inspection of the scatterplots of the association between the five personality 
traits and changes in outcome measures (four scales in total) in response to treatment, it 
was difficult to establish linearity due to the small sample size, though it was evident that 
there was a large number of tied outcomes (primarily scores of “0” on the amount of 
change on the outcomes measure scales).  
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Therefore, a non-parametric alternative to the Pearson correlation was required, 
that is, Kendall rank correlation (i.e. Kendall’s tau-b) or Spearman correlation. Kendall’s tau-
b is recommended when data contains tied ranks and a small sample (e.g. Field, 2009), as 
was the case in the present study, therefore it was chosen as the analysis method. The two 
statistical assumptions for Kendall’s tau-b are that (a) the two variables should be 
measured on an ordinal or continuous scale, and (b) representing paired observations; both 
assumptions were satisfied.  
Reliable Change Index and Clinically Significant Change: Individual Scores 
The standard error of measurement and Reliable Change Scores for each measure, 
against which each individual’s data was compared to determine whether they had made 
reliable significant change, can be found in Table 20. Figures 2–5 show plots for each 
outcome measure scale, with individuals’ pre- and post-treatment data points (T1 and T2), 
in relation to the RCI and using Jacobson et al.’s (1984) “Criterion a” to calculate cut-offs for 
clinically significant change. A decrease in scores indicates a decrease in clinical need on 
both measures (i.e. functional improvement).  
Table 19. Standard Error of Measurement (SEM) and Reliable Change Scores (RCS) for the 
Change in Scores on Each Ouctome Measure Scale (n = 16) 
 SEM RCS 
HoNOS-secure   
Clinical 2.83 7.86 
Security 2.71 7.50 
HCR-20V3   
Clinical 0.68 1.89 
Risk 0.72 2.00 
Abbreviations: HCR-20V3, Historical Clinical Risk Management-20, Version 3; HoNOS-secure, 
Health of the Nation Outcome Scale-secure. 
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Note. The SD for the clinical population was large therefore the cut-off score for CSC 
calculated with “Criterion a” (Jacobson et al., 1984) was -0.35. However, “0” is the lowest 
possible score on the HoNOS-secure, therefore no cut-off score applied to this scale and no 
individuals made CSC.  
Abbreviation: HoNOS-secure, Health of the Nation Outcome Scale-secure. 
 




































Figure 3. Plot of Individuals' Pre- and Post-Treatment scores on HoNOS-secure - Security 








































Figure 2. Plot of Individuals' Pre- and Post-Treatment scores on HoNOS-secure - Clinical 
Scale, Indicating Reliable Change Index (RCI) and Clinically Significant Change (CSC) (n = 16) 
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Abbreviation: HCR-20V3, Historical Clinical Risk Management-20, Version 3. 
 










































Figure 4. Plot of Individuals' Pre- and Post-Treatment scores on HCR-20V3 Clinical Scale, 









































Figure 5. Plot of Individuals' Pre- and Post-Treatment scores on HCR-20V3 Risk Scale, 
Indicating Reliable Change Index (RCI) and Clinically Significant Change (CSC) (n = 16) 
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Associations Between Personality Traits 
To contribute to research on the PID-5, a Kendall's tau-b correlation was run to 
determine whether there were significant associations amongst the DSM-5 personality 
traits (using a two-tailed test of significance). As seen in Table 21, all traits besides 
Antagonism showed non-significant associations with other traits that were weak or 
moderate. Antagonism was the only trait to have no associations with any other trait. Only 
one significant association was seen, which was a moderate positive association between 
Detachment and Psychoticism (p = .005). Several non-statistically significant associations 
were seen. Detachment also showed a weak positive correlation with Disinhibition, and a 
moderate positive association with Negative Affect. Psychoticism additionally showed a 
moderate positive association with Negative Affect and a weak positive association with 
Disinhibition. A weak positive association was seen between Disinhibition and Negative 
Affect.  
 
Table 20. Correlations Between DSM-5 Personality Traits (τb) (n = 16) 
DSM-5 Personality Trait M (SD) 1 2 3 4 
1. Negative Affect 1.28 (0.61) 
    
2. Antagonism 0.54 (0.46) -.06 
   
3. Disinhibition 1.17 (0.55) .25 -.10 
  
4. Detachment 0.92 (0.55) .40 -.13 .22 
 
5. Psychoticism 0.93 (0.62) .40 .14 .22 .46* 
Abbreviation: PID-5, Personality Inventory for the DSM-5.  
*p < 0.01, two-tailed, significant once adjusted using Holm-Bonferroni post hoc to account 
for familywise error rates.  
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Voluntary Status 
As can be seen in Figure 6, responses for whether participants believe they should 
be in hospital for treatment varied greatly, with 25% (n = 5) rating the minimum, and 25% 
rating the maximum (M = 5.65, SD = 3.65). It was not possible to analyse correlation 
between voluntary status and response to treatment and personality traits as the data did 
not meet parametric assumptions (the data was not linear or normally distributed) nor 
assumptions for non-parametric correlation analysis (i.e. Kendall’s tau and Spearman 
correlation) as visual inspection of the scatterplots for the relationship between voluntary 
status and change on the HoNOS-secure and HCR-20V3 scales revealed that the data was 
not monotonic and therefore precluded the usefulness of the analysis. Given that the 
responses constituted direct responses rather than observed effects, it would not have 
been appropriate to transform the data into a monotonic spread. The spread of the data 




























Likert Rating for Voluntary Status 
Figure 6. Frequency of Ratings for Voluntary Status  (N = 20) 
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Non-Significant Correlation Between Personality Traits and Treatment Outcome 
As presented in the Empirical Paper Results section (p. 89), while no significant 
correlations were found between personality traits and treatment outcomes on the 
HoNOS-secure and HCR-20V3, several weak associations were seen as well as one moderate 
association. This is of note, as the available sample size could only detect correlations larger 
than .6. In particular, one association was close to attaining significance, and was the sole 
moderate association. Antagonism had a moderate negative correlation with change on the 
HCR-20V3 Risk scale (τb = -.309, p = .055), suggesting that patients with greater Antagonism 
showed less change in risk factors. This fits with the findings of Miller and Lynam (2001), 
that Agreeableness (from the five-factor model [FFM]; Costa & McCrae, 1990) was 
negatively correlated with antisocial behaviours (which would correspond to a positive 
correlation with Antagonism, as seen in Table 13, p. 71). 
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Chapter 7: Discussion and Critical Evaluation 
This chapter provides a discussion of the Additional Results from the Empirical Paper, 
presented in the previous chapter, as well as building on the Discussion sections of the 
Systematic Review and Empirical Paper, and the Extended Methodology chapter, to provide 
a discussion and critical evaluation of the thesis portfolio as a whole. Reflections on the 
research process are presented, as well as the theoretical and clinical implications of the 
findings, and recommendations for future directions in research. 
 Extended Discussion for Empirical Paper Additional Results 
Associations Between Personality Traits 
A significant positive correlation was seen between Detachment and Psychoticism. 
This is consistent with existing literature; whilst research into the DSM-5 model is still in its 
early stages, the FFM correlates for these two traits, Extraversion and Openness (inversely 
correlated, as seen in Table 13, p. 71), have consistently been found to be significantly 
associated (e.g. Aluja et al., 2002; Costa & McCrae, 1992; Zuckerman et al., 1993). 
Researchers have suggested that this is in fact due to the two traits “sharing an important 
amount of common variance, suggesting that these two dimensions are not independent” 
(Aluja et al., 2003, p. 672). 
Voluntary status 
As explained in the Methods and Discussion sections of the Empirical Paper (p. 84 
and p. 95), it was not possible to analyse the relationship between participants’ agreement 
with their need for treatment and their outcomes, nor any relationship with personality 
traits, due to the small sample size. The chosen measure for this however had limitations. 
Single-item measures generally suffer from poor reliability and criterion validity when used 
for complex constructs (Sarstedt & Wilczynski, 2009). In this case, it is likely that the 
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question did not capture nuances of motivation and beliefs about treatment. For example, 
it is possible that individuals may feel that they do need treatment but not in hospital, or 
that the treatment they are receiving is not the right one. The question could also be 
interpreted as agreement with a custodial sentence or involuntary detention under the 
MHA. Additionally, it is impossible to separate confounding variables such as individuals’ 
affect whilst responding. For example, their response could be influenced by factors such as 
recent events and interpersonal relations. Therefore, this measure likely did not adequately 
capture participants’ motivation, which is a factor that relates to “the competing demands 
of therapy rehabilitation and security” (Hodge and Renwick, 2002).  
In addition, the small sample size prevented analysis of the relationship between 
participants’ level of security and their motivation and treatment outcomes. Level of 
security has been postulated to be relevant for motivation and engagement (e.g. Long et al., 
2011). In the good lives model, McMurran and Ward (2004) suggest that having a greater 
proportion of treatment programme elements that build skills that can facilitate the 
achievement of patients’ goals, rather than focus primarily on risk management, will 
maximise motivation for change and satisfaction with the treatment. Accordingly, the shift 
in this balance created by different levels of security (i.e. more risk management required in 
high compared to medium and low security levels, respectively), may correspond to 
increased motivation and satisfaction (Long et al., 2011). 
 Critical Evaluation 
The strengths and limitations of the methodology used in the Systematic Review 
and the Empirical Paper are evaluated in their respective Discussion sections (p. 42 and p. 
90, respectively). Additionally, both the planned and alternative methodology employed for 
the Empirical Paper (due to recruitment difficulties) are critically evaluated in the Extended 
Methodology chapter (p. 107), and therefore will not be replicated here. Overall, the 
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reliability and interpretation of the findings of the two studies is limited with regards to 
understanding the role that personality traits have in the outcomes of psychological 
interventions, as well as outcomes of multimodal treatment in forensic mental health 
services. Nevertheless, the particulars of their findings are important, with regards to their 
theoretical, clinical and ethical implications. Elements of the chosen methodologies, as well 
as possible alternatives, will be discussed alongside these sections, with suggestions for 
required future research approaches. 
Systematic Review Line of Enquiry and Approach 
The approach employed in the Systematic Review was robust in systematically 
identifying, assessing and synthesising the available evidence base, using a clearly defined 
set of inclusion criteria. As a result, few studies were identified, which is likely the result of 
a limited amount of research available into predictors of outcomes of empirically supported 
(in this case recommended by the National Institute for Health and Care Excellence [NICE] 
guidelines) psychological interventions, specifically looking at personality traits. Therefore, 
in order to continue to learn about the role of client-specific idiosyncratic factors such as 
personality traits in the course of treatment, an alternative methodology may be 
recommended. Realist synthesis (Pawson et al., 2005) is an alternative to meta-analysis and 
narrative synthesis of systematic reviews, originally presented for use in “complex social 
interventions which act on complex social systems”. It may also be useful for psychological 
interventions, when seen as complex processes, where the mechanism of change relies on 
many co-variables, stemming from clients, therapists, therapeutic framework/intervention 
and context (as explored in the Introduction chapter, p. 10). It aims to distil “what works for 
whom, in what circumstances, in what respects and how” (Pawson et al., 2005, p. 21). To 
do this, researchers (a) make explicit “the underlying assumptions about how an 
intervention is meant to work and what impacts it is expected to have” (p. 21), (b) identify 
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empirical evidence for this framework, and (c) “focus on explaining the relationship 
between the context in which the intervention is applied, the mechanisms by which it 
works and the outcomes which are produced” (p. 21). This approach would be useful in 
such a complex area, with numerous possible influences, from both therapeutic 
framework-specific and non-therapeutic framework specific factors, was well as procedural 
elements. Realist synthesis has also been recommended for use in research into treatment 
effectiveness in FMHS. Hockenhull et al. (2015) reviewed the sample of included studies 
from two systematic reviews into interventions to reduce or prevent interpersonal violence. 
They found that the studies were too heterogeneous to allow meaningful synthesis, even 
by division into distinct groups. Their conclusion was that either a “major topic 
prioritization exercise” (p. 18) is needed to focus research, or to employ a realist synthesis 
approach, to understand “what works, for whom, and in what context” (p. 18). 
Theoretical Implications 
The Role of Personality Traits in Predicting the Course and Outcome of Treatment 
The Systematic Review and Empirical Paper were both unable to find evidence of a 
significant predictor role for FFM personality traits in treatment outcomes neither from 
psychological therapies; nor a significant correlation with treatment outcomes in FMHS. 
However, limitations in both studies impacted the reliability of these findings (as discussed 
in both articles’ Discussion sections), mainly through a distinct sparsity of available studies 
for the Systematic Review, and a lack of significant treatment outcomes in the Empirical 
Paper. It is not possible therefore to conclude whether personality traits do have a 
significant role in determining engagement and outcome from treatment. However, a 
further question arises in this field of research, which affects the study of this relationship—
the theoretical construct of personality, and whether personality traits are stable. 
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The Stability of Personality Traits. There is substantial longitudinal evidence that 
traits change naturally over the life span, related to changes in individuals’ lives, which has 
been consistent across a number of studies (e.g. Roberts et al., 2006; Specht et al., 2011; 
Terracciano et al., 2005). Researchers have shown that during the period of adolescence, 
when people become more aware of social judgement, and go through a period of 
increased connection with peers, as well as exploration of their identity and place in the 
world, adolescents have higher Neuroticism, Extraversion and Openness. At the same time, 
with a combination of developing frontal lobe structures and corresponding impulse control, 
as well as hormonal changes, they can be more critical of others, struggle to understand 
consequences and seek instant gratification, with corresponding lower Agreeableness and 
Conscientiousness than that of adults. Extraversion and Openness then decline over the 
lifespan, whilst Agreeableness increases. Conscientiousness however increases from 
adolescence to early adulthood and then decreases again into later adulthood, whilst 
Neuroticism has been seen to increase in middle age and then decline in older age, as older 
adults become less afraid of social evaluation and become more inclined to defend their 
beliefs (Roberts et al., 2006; Terracciano et al., 2005). This pattern has been seen across 
cultures (Terracciano & McCrae, 2006).  
The stability of people’s personality traits, or their propensity for change due to 
outside experiences, has been long debated. Some researchers believe that traits are 
amenable to change, and have explored them as an outcome of therapy, where studies 
have shown a significant change in reported traits post-treatment (Roberts et al., 2017). A 
possible explanation for these changes could lie in the nature of the methods for measuring 
personality. The most common method for measuring personality traits is using self-report 
questionnaires. Whilst research has shown that individuals experiencing clinical disorders 
such as depression tend to display higher levels of Neuroticism, it has also been shown that 
individuals experiencing a major depressive episode think of themselves more negatively, 
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so are more likely to answer a personality measure in a way that will make them score 
highly in more “undesirable” or maladaptive traits than they actually have (Bagby et al., 
2008). If they are thinking of their actions in recent times, their answers may be more about 
their symptomology than their more pervasive personality traits (Hirschfeld et al., 1983). 
Furthermore, the common designs for intervention studies may also pose challenges to the 
interpretation of findings—as personality is measured at pre-treatment (whilst actively 
experiencing symptomology), the change following therapy may be state-dependent; 
reflecting change in the disorder rather than a change in their traits (Du et al., 2002). 
On the other side of the argument, personality traits are considered a temporally 
stable construct (McCrae & Costa, 1996). Proponents of this argue that environmental 
effects on personality traits have seldom been replicable (e.g. Bouchard & Loehlin, 2001; 
Neyer & Asendorpf, 2001). The original authors of the FFM wrote that the debate is 
misrepresented, as “stable does not mean immutable” (Costa & McCrae, 2006). They agree 
with findings that changes occur with age, and have posed that this may occur due to either 
environmental influences common to all cultures or biologically based intrinsic maturation, 
and they believe the later has more credence (p. 27). In their five-factor theory of 
personality, built upon the growing evidence base into the possible mechanism of 
personality based on the use of their instruments (NEO Personality Inventory – Revised, and 
NEO Five-Factor Inventory; Costa and McCrae, 1992) across many countries, McCrae and 
Costa (1999) posit that there are distinct parts to personality. The FFM are basic tendencies, 
which are “abstract psychological potentials” (p. 143) that are “directly accessible neither 
to public observation nor private introspection” (p. 143). They are biologically based and do 
not change, whilst characteristic adaptations (the concrete manifestations of the basic 
tendencies; e.g. behaviour, personal strivings and attitudes) are influenced by the basic 
tendencies as well as dynamic processes and external influencers. Therefore, it may be 
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these characteristic adaptations that are inadvertently captured and discussed when 
measuring and exploring personality traits. 
Challenges to studying this state versus trait construct of personality due to 
empirical research designs and measurement methods, limit the reliability of both sides to 
the argument. Moreover, the framework chosen impacts the available evidence base (both 
empirical and review). For example, both studies presented in this thesis adopted the view 
that traits are stable; in the Empirical Paper this meant that a cross-sectional design was 
used, and personality was measured only post-treatment, which would not capture any 
change which may have occurred in personality throughout (or as a result of) treatment. 
Similarly, in the Systematic Review, all identified studies considered only baseline trait 
scores to correlate with outcomes, without measuring traits post-treatment. As with the 
Empirical Paper, it is not possible to know if change in personality traits occurred. It could 
be said that this impedes meaningful interpretation of treatment predictor findings, since 
we cannot be sure that the assessed traits were temporally stable constructs rather than, 
for example, symptom-related, and therefore what these findings signify. Whilst it was not 
possible to compare pre- and post-treatment personality traits, as the service does not 
routinely use any personality measures for all patients, a possible alternative could have 
been to collect personality measures at two time points, with a substantial period in 
between (e.g. 6-12 months or as long as possible within research-period constraints). 
However, given the difficulties with recruitment outlined in the Extended Methodology 
chapter (p. 110), this may not be feasible.  
It is important therefore to continue to understand more about the function of 
personality, to be able to learn more about the mechanisms of clinical disorders as well as 
treatment for them. Future research may benefit from administering personality measures 
at multiple time points to view whether personality traits have changed alongside other 
outcomes, and balancing this with a consideration of whether baseline levels of traits 
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predict outcomes (i.e. if personality traits have changed then this would not be a sound 
investigation). Researchers are encouraged not to adopt one side of the state versus trait 
argument exclusively. 
Clinical Implications of the Empirical Paper 
Treatment Outcomes in FMHS 
As described in the Bridging Chapter (p. 66) and Empirical Paper Introduction and 
Discussion sections (p. 75 and p. 91, respectively), outcomes of treatment in U.K. FMHS are 
generally poor, with high levels of recidivism and re-admission (e.g. Coid et al., 2007, Davies 
et al., 2007). The empirical paper found a lack of significant change in clinical and risk 
outcomes following a minimum of 18 months in FMHS. This raises important clinical and 
ethical implications, which are discussed in the Empirical Paper Discussion section (p. 97). 
Treatment in FMHS involves a deprivation of liberty (see Empirical Paper Introduction 
section p. 75), deemed necessary for the wellbeing and safety of patients and the public, 
and is intended to be time bound, with the aim to improve the patient’s symptomology, 
distress and risk to themselves and others. The findings of the present study, and several 
other studies (some of which have been discussed in this thesis portfolio, e.g. Coid et al., 
2007; Davies et al., 2007; Longdon et al., 2018), where treatment effectiveness has not 
been established, must therefore be considered seriously. The potential implications 
include inappropriate deprivation of liberty (as it does not fulfil the intended purpose), and 
ineffective use of public funds. Creating a national database of routinely collected 
outcomes measures could allow for organising large-scale evaluation of FMHS, similarly to 
the U.K. Improving Access to Psychological Therapies (IAPT) service, to allow for the 
establishment of a robust evidence base and inform best practice (and areas of further 
research).  
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Measuring Outcome of Treatment in FMHS 
As well as the findings for outcomes of treatment, the tools used to measure and 
evaluate change are important and a key issue in FMHS which was highlighted by the 
Empirical Paper.  
There are a number of different assessed outcomes in mental health services 
(including FMHS), which include symptom reduction, patient-defined outcomes (e.g. goals 
or subjective experience), improvement in Quality of Life (i.e. adaptive functioning), 
intermediate events or goals based on the chosen intervention’s theoretical framework and 
therapist’s assumptions, possible negative outcomes (or unintended consequences), and 
health-economic outcomes (Cuijpers, 2019). Most clinical research in FMHS prioritises 
symptom reduction, and behavioural risk-related outcomes.  
The Empirical Paper sought to explore the relationship between DSM-5 personality 
traits and changes in a broad range of clinical outcomes. Whilst deciding which treatment 
outcome measures to use for the study, the list of outcomes considered pertinent to the 
needs of the forensic population in Shinkfield and Ogloff’s (2014) review of routine 
outcome measures (ROMs) for forensic mental health services (FMHS) was considered. This 
includes domains of functioning (clinical/psychosocial), recovery, risk, and placement 
pathway, as shown in Table 19. 
Local clinicians from the planned recruitment services were contacted to ascertain 
which ROMs, that cover outcomes from these domains, are routinely administered and 
completed for most patients in both services. It was found that only the HoNOS-secure and 
HCR-20V3 were completed as standard; the HoNOS-secure is commissioned (NHS England; 
2014, 2018a, 2018b), and HCR-20V3 is recommended (Department of Health and Social Care, 
2009) for use in FMHS. Neither measure covers all the domains listed in Table 19, though 
this is also the case for all ROMs reviewed by Shinkfield and Ogloff (2014). Despite this, the 
HoNOS-secure is one of the ROMs that they recommended for use in FMHS, as it was found 
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Table 21. Treatment Needs for the Forensic Mental Health Services Population 
Domain Treatment Needs 
Functioning Psychiatric symptoms  
(clinical/psychosocial) Psychosocial  
 Relationships (including social withdrawal)  
 Personality 
 Activities of Daily Living  
 Cognitive 
 Insight (Mental health, offending) 
 Physical health 
 Vocational (including activities) 
Recovery Client perspective of Recovery 
 Service perspective of Recovery 
Risk to SELF 
 to OTHERS 
 of SUBSTANCE USE 
 of RE-OFFENDING 
  Violence 
  Sexual violence 
  General recidivism 
Placement Pathway Level of security required (i.e., low, medium or high)  
 Whether current security placement is appropriate  
 Legislative requirements 
  Purpose of treatment (mental health, offending) 
Note. Adapted from “A review and analysis of routine outcome measures for forensic 
mental health services” by G. Shinkfield, and J. Ogloff, 2014, International Journal of 
Forensic Mental Health, 13(3), 256. Copyright 2014 by Informa UK Limited. 
 
to cover most of the domains, be brief and easy to use, provide quantitative data, have a 
research base, have established psychometric properties and be applicable for both 
inpatient and outpatient FMHS. The previous version of the HCR-20 (Version 2, Webster et 
al., 1997) was not one of the recommended tools, due to covering a limited range of 
functioning domains, which is to be expected from a specific assessment tool for violence, 
as well as not being brief or easy to use as it requires formal training and experience to 
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administer, and consideration of a large volume of data from numerous sources. 
Nevertheless, it is a well-established measure for the assessment and risk-management 
planning for violence and provides a good overview of risk factors, which were a focus for 
the study. Therefore, it was decided that the HCR-20V3 would also be used to provide as 
much clinical data as possible.  
This emphasised some of the challenges of researching treatment effectiveness in 
FMHS; the breadth of relevant outcomes and their intricate relationship, and the sparsity of 
standardised measurement of these many outcomes. Indeed, one of the senior local 
clinicians expressed that this discussion had led her to believe that the ROMs routinely 
collected by the service are not sufficient and they would consider undertaking a service 
evaluation project to look at which measures could be added to their ROMs to provide the 
most useful information for ongoing evaluation, treatment-planning and clinical decision-
making. It is interesting to note that Personality is one of the treatment needs (i.e. areas 
subject to change in treatment) in Shinkfield and Ogloff’s (2014) review, positing their 
position in the debate about the constructs of personality, discussed above. It is evident 
that gathering routine outcome measurement in forensic services is challenging, and the 
measures used focus primarily on the treatment needs identified by stakeholders. Focusing 
research on this however may not capture change that is meaningful, in individuals with 
complex difficulties, which stem from many sources. In recent years research has turned to 
the meaning of success in treatment.  
Recovery Focus. When Livingston (2016) examined the complexity of the idea of 
“success” in FMHS treatment from the perspectives of patients and service providers, they 
found that collectively six themes arose: normal life, independent life, compliant life, 
healthy life, meaningful life, and progressing life. This shows that people who provide or 
use FMH services emphasize a broad range of processes and outcomes, apart from public 
safety, when they think about success. FMHS in the UK are currently using a recovery and 
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outcomes-based approach called My Shared Pathway (part of the Department of Health 
Quality, Innovation, Productivity and Prevention Programme for Secure Services), which is 
completed by patients, supported by their key workers. The seven outcome areas are; My 
mental health recovery; Stopping my problem behaviours; Getting insight; Recovery from 
drug and alcohol problems; Making feasible plans; Staying healthy; My life skills; and My 
relationships. This measure of subjective experience of progress is central to the evaluation 
of treatment and any related decision-making, showing how key these elements are as 
outcomes of treatment, though not captured by the HoNOS-secure and HCR-20V3. It stands 
to reason that research into treatment effectiveness should include recovery focused 
outcomes, to build a holistic picture of the outcomes, alongside behavioural, symptom-
reduction and health-economic considerations. 
Future Research isnto Outcomes of Treatment in FMHS 
The need to better evaluate treatment effectiveness in FMHS remains. Large 
recruited sample sizes are needed and various areas of outcomes should be explored along 
with behavioural outcomes, including: the need for clinical intervention and risk 
management, specific established measures of symptomatology relevant to each patient 
(e.g. a measure of psychotic symptoms for patients who have diagnoses of Psychotic 
Disorders and are receiving interventions for this), motivation, satisfaction with treatment, 
and recovery-focussed patient-identified outcomes. Both clinician- and patient-rated 
measures should be used to evaluate subjective improvement (and therapeutic alliance). In 
addition, utilising a large sample size spanning different levels of security would allow for 
comparison between these settings and help to understand how environmental and 
procedural differences impact change, further shedding light on the process of change and 
recovery following treatment in FMHS. Finally, establishing a national database of ROMs 
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from FMHS would overcome some of the challenges in attaining a substantial sample size, 
to allow for adequately powered analysis, as well as greater external validity. 
 Conclusion 
As stated in the Introduction chapter, the studies in this thesis portfolio sought to 
examine whether personality is a significant idiosyncratic predictive factor for outcomes 
following psychological intervention and treatment in FMHS, to consider whether there is 
strong evidence to suggest that it may play a role in the mechanism of change in 
psychological intervention. It is not possible to meaningfully interpret the predictive value 
of personality traits for outcomes of both psychological intervention and treatment from 
the findings of the present studies. 
As evidenced by the findings of the Systematic Review, it can be difficult to 
disentangle personality from many other variables which may have an impact on treatment 
outcomes. Therefore, one may ask whether there remains a rationale to continue exploring 
the relationship between personality and treatment outcomes, and the role that 
personality may play in the mechanism of change. It is important to understand the 
mechanism of change in psychological intervention to help improve outcomes for 
individuals, by choosing the correct treatments for them, making necessary adaptions, as 
well as making improvement to the treatments themselves if necessary. The lack of findings 
for predictive value of personality traits for outcomes, coupled with findings that other 
idiosyncratic variables were significant predictors whenever also examined, indicates that 
personality would not have a central role in the mechanism of action and predicting 
outcome on its own. However, it is likely to have a mediating role in the development of 
other factors which may be more central to the mechanism of change, such as therapeutic 
alliance, which has been shown to significantly predict outcome of psychological 
interventions (Martin et al., 2000). 
 140 
The study of potential individual predictors of change is not bringing the research 
community closer to understanding the mechanism of change in psychological therapy or 
treatment in FMHS, especially through a body of research that is very heterogenous. To 
meaningfully undertake research into the mechanism of change it is important to do so top 
down – by establishing a hypothesised theory for the mechanism of change which can be 
tested. Arguably, understanding the exact role of each individual contributing factor is not 
feasible, nor as important, as gaining empirical support and therefore understanding of the 
interplay of a multitude of factors. Indeed, individuals do not represent delineated 
extremes of factors, rather a complex embodiment of factors, affected by their 
biopsychosocial experience. 
Therefore, using a method of creating conceptual understanding of the mechanism 
of intervention, such as realist synthesis, would allow the research community to build a 
unified theory of mechanism of change in psychological intervention, including relevant 
common factors, both for psychological interventions, and multimodal treatment in FMHS. 
This would bring greater consensus and orient research to empirically test the proposed 
mechanisms, ideally by examining their mediator roles (which would show how their 
presence impacted outcome over the course of treatment). Previous attempts to synthesise 
available research (e.g. Lemmens et al., 2016) or predictive or mediating factors, including 
the present systematic review, have shown that the evidence base is very heterogenous. 
Consensus is needed for research methods, including design, analysis methods and 
standardisation of assessment instruments. Measurement of potential variables should be 
done at baseline, mid-treatment, and post-treatment to allow for reliable and meaningful 
interpretation of the relationship between factors and therefore their mechanism.  
In addition, research into the mechanisms of change in individual therapies has 
tested the role of theoretical constructs, rather than actual techniques (Petrik & Cronin, 
2014). It is important to establish ways to measure actual delivered techniques rather than 
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hypothesised theoretical constructs. This is particularly important for research comparing 
the effectiveness of interventions; while they may vary by philosophical construct, the 
therapeutic techniques delivered may not contrast in practice. This would be important to 
understand when interpreting and testing the interventions’ mechanisms of action, as well 
as allowing to target change and improvement in interventions, by understanding the value 
of individual techniques.  
If personality traits, amongst other factors, were found to have a significant 
mediator role in the mechanism of action for psychological interventions, a potential risk 
could be that some clinicians may erroneously interpret that individuals with certain 
personality profiles, or other measured factors, would not benefit from certain therapies, 
and therefore restrict access to those interventions. This should not occur without explicit 
evidence that certain therapies may cause specific harm or poor outcomes for individuals 
with specific profiles, which the current evidence base, and employed methodologies, do 
not provide, and clinicians would have to remember that research provides evidence of 
statistical links between factors, whilst a complex mechanism of multiple factors will be 
relevant, which we do not yet understand. Furthermore, clinical judgement (following 
professional guidelines) still needs to be applied to best meet the particular treatment 
needs of individuals (whose profiles will be individual), as well as, most importantly, clients’ 
own preference. Instead, as with the current system of clinical application of evidence base 
(e.g. NICE Guidelines), gaining further understanding of what work best for whom and 
when, should provide support in treatment planning for clinicians. This would help them 
consider what measured factors (including personality traits) may affect individuals’ 
response to treatment, allowing them to make adaptations to facilitate clients’ uptake and 
improvement. For example, providing increased structure and considering practical support 
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Appendix A. Systematic Review Journal Formatting Guidelines 
Personality and Individual Differences – Guide for Authors 
Relevant extract retrieved from: https://www.elsevier.com/journals/personality-and-
individual-differences/0191-8869/guide-for-authors 
Additional Information: Article Types and Length 
Manuscripts must be submitted using double-spacing including line and page numbers. 
These should not exceed the word count provided below. The word count includes: title, 
abstract, full text, references and footnotes/acknowledgements. Tables and figures are not 
considered in the word count but only those essential to the study should be included in 
the body of the paper; all other tables, etc. should be placed as supplemental material. 
Lengthier reviews, theoretical and expository articles, and meta-analyses: Articles of 
exceptional quality and importance will be considered for publication and typically be no 
more than 10,000 words. Longer papers may be submitted and will be considered at the 
discretion of the editors; in your covering letter, please justify why you are requesting 
greater than 10,000 word count. 
Review articles: These papers are typically in the 5,000-10,000 word range and provide a 
critical analysis of important and new topics related to personality and individual 
differences. Please select Review Article from the dropdown menu upon submission. 
Single study research articles: Single study research articles should not exceed 5000 words. 
PREPARATION 
Reporting Requirements: 
All empirical submissions are required to: (a) provide sufficient detail on the samples 
studied and the population from which they constitute a random or convenience sample; 
(b) compile basic descriptive statistics of all variables of relevance used in the study (e.g., 
indices of central tendency and dispersion; reliability coefficients for scale scores); and (c) 
report effect sizes for focal tests (correlations r and regression weights beta count as effect 
size measures). In addition to these required reporting practices, we encourage but do not 
strictly require (a) providing 95% CIs around focal effect size estimates, (b) detailing any a 
priori power considerations made that led to the final sample size, and (c) whether and 
where any data, materials, code or syntax, or additional analyses of the reported studies 
can be found openly accessible; authors may include such information as “supplemental 
information” for inclusion in the online publication. 
Power: 
For empirical studies, we recommend but do not strictly require at least 80% power for 
focal statistical tests. 
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References 
There are no strict requirements on reference formatting at submission. References can be 
in any style or format as long as the style is consistent. Where applicable, author(s) name(s), 
journal title/book title, chapter title/article title, year of publication, volume number/book 
chapter and the article number or pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article 
by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for 
the author to correct. 
Formatting requirements 
There are no strict formatting requirements but all manuscripts must contain the essential 
elements needed to convey your manuscript, for example Abstract, Keywords, Introduction, 
Materials and Methods, Results, Conclusions, Artwork and Tables with Captions. 
If your article includes any Videos and/or other Supplementary material, this should be 
included in your initial submission for peer review purposes. 
Divide the article into clearly defined sections. 
Figures and tables embedded in text 
Please ensure the figures and the tables included in the single file are placed next to the 
relevant text in the manuscript, rather than at the bottom or the top of the file. The 
corresponding caption should be placed directly below the figure or table. 
Article structure 
Subdivision - numbered sections 
Divide your article into clearly defined and numbered sections. Subsections should be 
numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section 
numbering). Use this numbering also for internal cross-referencing: do not just refer to 'the 
text'. Any subsection may be given a brief heading. Each heading should appear on its own 
separate line. 
Introduction 
State the objectives of the work and provide an adequate background, avoiding a detailed 
literature survey or a summary of the results. 
Material and methods 
Provide sufficient details to allow the work to be reproduced by an independent researcher. 
Methods that are already published should be summarized, and indicated by a reference. If 
quoting directly from a previously published method, use quotation marks and also cite the 
source. Any modifications to existing methods should also be described. 
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Theory/calculation 
A Theory section should extend, not repeat, the background to the article already dealt 
with in the Introduction and lay the foundation for further work. In contrast, a Calculation 
section represents a practical development from a theoretical basis. 
Results 
Results should be clear and concise. 
Discussion 
This should explore the significance of the results of the work, not repeat them. A 
combined Results and Discussion section is often appropriate. Avoid extensive citations and 
discussion of published literature. 
Conclusions 
The main conclusions of the study may be presented in a short Conclusions section, which 
may stand alone or form a subsection of a Discussion or Results and Discussion section. 
Appendices 
If there is more than one appendix, they should be identified as A, B, etc. Formulae and 
equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a 
subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, 
etc. 
Essential title page information 
• Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible. 
• Author names and affiliations. Please clearly indicate the given name(s) and family 
name(s) of each author and check that all names are accurately spelled. You can add your 
name between parentheses in your own script behind the English transliteration. Present 
the authors' affiliation addresses (where the actual work was done) below the names. 
Indicate all affiliations with a lower-case superscript letter immediately after the author's 
name and in front of the appropriate address. Provide the full postal address of each 
affiliation, including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. This responsibility includes answering any 
future queries about Methodology and Materials. Ensure that the e-mail address is given 
and that contact details are kept up to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the 
article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') 
may be indicated as a footnote to that author's name. The address at which the author 
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actually did the work must be retained as the main, affiliation address. Superscript Arabic 
numerals are used for such footnotes. 
Highlights 
Highlights are optional yet highly encouraged for this journal, as they increase the 
discoverability of your article via search engines. They consist of a short collection of bullet 
points that capture the novel results of your research as well as new methods that were 
used during the study (if any). Please have a look at the examples here: example Highlights. 
Highlights should be submitted in a separate editable file in the online submission system. 
Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 
characters, including spaces, per bullet point). 
Abstract 
An abstract, not exceeding 200 words should constitute the first page of the article. 
Keywords 
Immediately after the abstract, provide a maximum of 8 keywords, reflecting the essential 
topics of the article, which may be taken from both the title and the text. These keywords 
will be used for information retrieval systems and indexing purposes. 
Abbreviations 
Define abbreviations that are not standard in this field in a footnote to be placed on the 
first page of the article. Such abbreviations that are unavoidable in the abstract must be 
defined at their first mention there, as well as in the footnote. Ensure consistency of 
abbreviations throughout the article. 
Acknowledgements 
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the title 
or otherwise. List here those individuals who provided help during the research (e.g., 
providing language help, writing assistance or proof reading the article, etc.). 
Formatting of funding sources 
List funding sources in this standard way to facilitate compliance to funder's requirements: 
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, 
yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the 
United States Institutes of Peace [grant number aaaa]. 
It is not necessary to include detailed descriptions on the program or type of grants and 
awards. When funding is from a block grant or other resources available to a university, 
college, or other research institution, submit the name of the institute or organization that 
provided the funding. 
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If no funding has been provided for the research, please include the following sentence: 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
Footnotes 
Footnotes should be used sparingly. Number them consecutively throughout the article. 
Many word processors build footnotes into the text, and this feature may be used. Should 
this not be the case, indicate the position of footnotes in the text and present the footnotes 
themselves separately at the end of the article. 
Figure captions 
Ensure that each illustration has a caption. A caption should comprise a brief title (not on 
the figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used. 
Tables 
Tables and figures should be constructed so as to be intelligible without reference to this 
text, each table and column being provided with a heading. Tables. Captions should be 
typewritten together on a separate sheet. The same information should not be reproduced 
in both tables and figures. 
References 
References should be prepared using the Publication Manual of the American Psychological 
Association for style. They should be placed on a separate sheet at the end of the paper, 
double-spaced, in alphabetical order. 
References should be quoted in the text by giving the author's name, followed by the year, 
e.g. (Hubbard & Ramachandran, 2001) or Hubbard and Ramachandran (2001). 
For more than two authors, all names are given when first cited, but when subsequently 
referred to, the name of the first author is given followed by the words et al., as for 
example--First citation: Reuter, Roth, Holve and Hennig (2006) but subsequently, Reuter et 
al. (2006). 
References to journals should include the author's name followed by initials, year, paper 
title, journal title, volume number and page numbers, e.g. 
[1] Nettle, D. (2006). Schizotypy and mental health amongst poets, visual artists, and 
mathematicians. Journal of Research in Personality, 40, 876-890. 
References to books should include the author's name followed by initials, year, paper title, 
editors, book title, volume and page numbers, place of publication, publisher, e.g. 
Fitzgerald, M. (2004). Autism and creativity: Is there a link between autism in men and 
exceptional ability? Hove and New York: Brunner-Routledge. 
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Or 
Thompson, J. (2006). The Mad, the ‘Brut’, the ‘Primitive’ and the Modern. A discursive 
history. In F. Andrada, E. Martin, & A. Spira (Eds.), Inner worlds outside (pp. 51-69). 
Dublin: Irish Museum of Modern Art. 
Web references 
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references should be listed separately 
after the reference list under a different heading - Web References. 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list (and 
vice versa). Any references cited in the abstract must be given in full. Unpublished results 
and personal communications are not recommended in the reference list, but may be 
mentioned in the text. If these references are included in the reference list they should 
follow the standard reference style of the journal and should include a substitution of the 
publication date with either 'Unpublished results' or 'Personal communication'. Citation of a 
reference as 'in press' implies that the item has been accepted for publication. 
Data references 
This journal encourages you to cite underlying or relevant datasets in your manuscript by 
citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add [dataset] 
immediately before the reference so we can properly identify it as a data reference. The 
[dataset] identifier will not appear in your published article. 
Reference formatting 
There are no strict requirements on reference formatting at submission. References can be 
in any style or format as long as the style is consistent. Where applicable, author(s) name(s), 
journal title/book title, chapter title/article title, year of publication, volume number/book 
chapter and the article number or pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article 
by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for 
the author to correct. If you do wish to format the references yourself they should be 
arranged according to the following examples: 
Journal abbreviations source 
Journal names should be abbreviated according to the List of Title Word Abbreviations. 
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Appendix B. Adapted Downs and Black (1998) Checklist for Measuring Study Quality 
Authors & Year:  
Reporting Yes = 1, 
No = 2 
1. Is the hypothesis/aim/objective of the study clearly described?  
2. Are the main outcomes to be measured clearly described in the Introduction or 
Methods section?   
If the main outcomes are first mentioned in the Results section, the question should 
be answered no. 
 
3. Are the characteristics of the patients included in the study clearly described?   
In cohort studies and trials, inclusion and/or exclusion criteria should be given. In 
case-control studies, a case-definition and the source for controls should be given. 
 
4. Are the interventions of interest clearly described?   
Treatments and placebo (where relevant) that are to be compared should be clearly 
described. 
 
5. Are the distributions of principal confounders in each group of subjects to be 
compared clearly described? * Only this question: Yes = 2, Partial = 1, No = 0 
A list of principal confounders is provided. 
* 
6. Are the main findings of the study clearly described?   
Simple outcome data (including denominators and numerators) should be reported 
for all major findings so that the reader can check the major analyses and 
conclusions. (This question does not cover statistical tests which are considered 
below). 
 
7. Does the study provide estimates of the random variability in the data for the 
main outcomes?   
In non normally distributed data the inter-quartile range of results should be 
reported. In normally distributed data the standard error, standard deviation or 
confidence intervals should be reported. If the distribution of the data is not 
described, it must be assumed that the estimates used were appropriate and the 
question should be answered yes. 
 
8. Have all important adverse events that may be a consequence of the intervention 
been reported?   
This should be answered yes if the study demonstrates that there was a 
comprehensive attempt to measure adverse events. (A list of possible adverse 
events is provided). 
 
9. Have the characteristics of patients lost to follow-up been described?  
This should be answered yes where there were no losses to follow-up or where 
losses to follow-up were so small that findings would be unaffected by their 
inclusion. This should be answered no where a study does not report the number of 
patients lost to follow-up. 
 
10. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the 
main outcomes, except where the probability value is less than 0.001? 
 
 Total:  
External Validity  Yes = 1,  
No/Unable To Determine = 0 
11. Were the subjects asked to participate in the study representative of the entire 
population from which they were recruited?  
The study must identify the source population for patients and describe how the 
patients were selected. Patients would be representative if they comprised the 
entire source population, an unselected sample of consecutive patients, or a 
random sample. Random sampling is only feasible where a list of all members of the 
relevant population exists. Where a study does not report the proportion of the 
source population from which the patients are derived, the question should be 
answered as unable to determine. 
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12. Were those subjects who were prepared to participate representative of the 
entire population from which they were recruited?  
The proportion of those asked who agreed should be stated. Validation that the 
sample was representative would include demonstrating that the distribution of the 
main confounding factors was the same in the study sample and the source 
population. 
  
13. Were the staff, places, and facilities where the patients were treated, 
representative of the treatment the majority of patients receive?  
For the question to be answered yes the study should demonstrate that the 
intervention was representative of that in use in the source population. The 
question should be answered no if, for example, the intervention was undertaken in 
a specialist centre unrepresentative of the hospitals most of the source population 
would attend. 
 
  Total:  
Internal Validity - Bias Yes = 1,  
No/UTD = 0 
14. Was an attempt made to blind study subjects to the intervention they have 
received? 
For studies where the patients would have no way of knowing which intervention 
they received, this should be answered yes. 
 
15. Was an attempt made to blind those measuring the main outcomes of the 
intervention? 
 
16. If any of the results of the study were based on “data dredging”, was this made 
clear?  
Any analyses that had not been planned at the outset of the study should be clearly 
indicated. If no retrospective unplanned subgroup analyses were reported, then 
answer yes. 
 
17. In trials and cohort studies, do the analyses adjust for different lengths of follow-
up of patients, or in case-control studies, is the time period between the 
intervention and outcome the same for cases and controls?  
Where follow-up was the same for all study patients the answer should yes. If 
different lengths of follow-up were adjusted for by, for example, survival analysis 
the answer should be yes. Studies where differences in follow-up are ignored should 
be answered no. 
 
18. Were the statistical tests used to assess the main outcomes appropriate? 
The statistical techniques used must be appropriate to the data. For example 
nonparametric methods should be used for small sample sizes. Where little 
statistical analysis has been undertaken but where there is no evidence of bias, the 
question should be answered yes. If the distribution of the data (normal or not) is 
not described it must be assumed that the estimates used were appropriate and the 
question should be answered yes. 
 
19. Was compliance with the intervention/s reliable? 
Where there was non compliance with the allocated treatment or where there was 
contamination of one group, the question should be answered no. For studies where 
the effect of any misclassification was likely to bias any association to the null, the 
question should be answered yes. 
 
20. Were the main outcome measures used accurate (valid and reliable)? 
For studies where the outcome measures are clearly described, the question should 
be answered yes. For studies which refer to other work or that demonstrates the 
outcome measures are accurate, the question should be answered as yes. 
 
Total:  
Internal validity - confounding (selection bias) Yes = 1,  
No/UTD = 0 
21. Were the patients in different intervention groups (trials and cohort studies) or 




For example, patients for all comparison groups should be selected from the same 
hospital. The question should be answered unable to determine for cohort and case 
control studies where there is no information concerning the source of patients 
included in the study. 
22. Were study subjects in different intervention groups (trials and cohort studies) or 
were the cases and controls (case-control studies) recruited over the same period 
of time? 
For a study which does not specify the time period over which patients were 
recruited, the question should be answered as unable to determine. 
 
23. Were study subjects randomised to intervention groups? 
Studies which state that subjects were randomised should be answered yes except 
where method of randomisation would not ensure random allocation. For example 
alternate allocation would score no because it is predictable. 
 
24. Was the randomised intervention assignment concealed from both patients and 
health care staff until recruitment was complete and irrevocable? 
All non-randomised studies should be answered no. If assignment was concealed 
from patients but not from staff, it should be answered no. 
 
25. Was there adequate adjustment for confounding in the analyses from which the 
main findings were drawn? 
This question should be answered no for trials if: the main conclusions of the study 
were based on analyses of treatment rather than intention to treat; the distribution 
of known confounders in the different treatment groups was not described; or the 
distribution of known confounders differed between the treatment groups but was 
not taken into account in the analyses. In non-randomised studies if the effect of the 
main confounders was not investigated or confounding was demonstrated but no 
adjustment was made in the final analyses the question should be answered as no. 
 
26. Were losses of patients to follow-up taken into account? 
If the numbers of patients lost to follow-up are not reported, the question should be 
answered as unable to determine. If the proportion lost to follow-up was too small 
to affect the main findings, the question should be answered yes. 
 
Total: 0 
Power Yes = 1,  
No/UTD = 0 
27. Did the study report having conducted a power analysis? Sample sizes have been 
calculated to detect a difference of x% and y%. 
  
28.  If yes - Did the study have sufficient power to detect a clinically important effect?  
Total: 0 
GRAND TOTAL: 0 
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Appendix C. Empirical Paper Journal Formatting Guidelines 
Journal of Forensic Psychology Research and Practice - ‘Instructions for Authors’ 
Relevant information retrieved from: 
https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=w
fpp21 
Preparing Your Paper 
Articles, Commentary, Practice Update, Case Report, and Ethics, Psychology and Public 
Policy 
Should be written with the following elements in the following order: title page; abstract; 
keywords; main text introduction, materials and methods, results, discussion; 
acknowledgments; declaration of interest statement; references; appendices (as 
appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list) 
Style Guidelines 
Please refer to these quick style guidelines when preparing your paper, rather than any 
published articles or a sample copy. 
Please use American spelling style consistently throughout your manuscript. 
Please use double quotation marks, except where “a quotation is ‘within’ a quotation”. 
Please note that long quotations should be indented without quotation marks. 
Formatting and Templates 
Papers may be submitted in Word or LaTeX formats. Figures should be saved separately 
from the text. To assist you in preparing your paper, we provide formatting template(s). 
Word templates are available for this journal. Please save the template to your hard drive, 
ready for use. 
If you are not able to use the template via the links (or if you have any other template 
queries) please contact us here.  
References 
Please use this reference guide when preparing your paper.  
[Link: https://www.tandf.co.uk//journals/authors/style/reference/tf_APA.pdf] 
Checklist: What to Include 
Author details. All authors of a manuscript should include their full name and affiliation on 
the cover page of the manuscript. Where available, please also include ORCiDs and social 
media handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the 
corresponding author, with their email address normally displayed in the article PDF 
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(depending on the journal) and the online article. Authors’ affiliations are the affiliations 
where the research was conducted. If any of the named co-authors moves affiliation during 
the peer-review process, the new affiliation can be given as a footnote. Please note that no 
changes to affiliation can be made after your paper is accepted.  
Funding details. Please supply all details required by your funding and grant-awarding 
bodies as follows: 
For single agency grants 
This work was supported by the [Funding Agency] under Grant [number xxxx]. 
For multiple agency grants 
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding 
Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number 
xxxx]. 
Disclosure statement. This is to acknowledge any financial interest or benefit that has 
arisen from the direct applications of your research. Further guidance on what is a conflict 
of interest and how to disclose it. 
Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 
dpi for color, at the correct size). Figures should be supplied in one of our preferred file 
formats: EPS, PDF, PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for 
figures that have been drawn in Word. For information relating to other file types, please 
consult our Submission of electronic artwork document. 
Tables. Tables should present new information rather than duplicating what is in the text. 
Readers should be able to interpret the table without reference to the text. Please supply 
editable files. 
Equations. If you are submitting your manuscript as a Word document, please ensure that 
equations are editable. More information about mathematical symbols and equations. 
Units. Please use SI units (non-italicized). 
Using Third-Party Material in your Paper 
You must obtain the necessary permission to reuse third-party material in your article. The 
use of short extracts of text and some other types of material is usually permitted, on a 
limited basis, for the purposes of criticism and review without securing formal permission. 
If you wish to include any material in your paper for which you do not hold copyright, and 
which is not covered by this informal agreement, you will need to obtain written permission 
from the copyright owner prior to submission. More information on requesting permission 
to reproduce work(s) under copyright. 
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Appendix D. Research Ethics Committee and Health Research Authority Letters 














Appendix E. Poster Advertising the Research Project 
	




Would you like to answer a questionnaire 
about yourself and have a chance to win a 
£15 Amazon voucher? 
 
 
A study is being run through the University of East Anglia to explore the link 





The meeting would last 60 – 90 minutes. You would be asked to complete 









Participants that take part in the study will be entered in a prize draw to win 




Alison Babitsky (Chief Investigator) will be coming soon to tell patients 




Speak to someone from the Psychology team for more information 
 
 
Thank you for reading this! 
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Appendix F. Expression of Interest and Consent to Contact Form 
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Appendix I. Health of the Nation Outcome Scale – Secure (Sugarman & Walker, 2007) 
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